High-Throughput Screening Market Report 2026-2031, By Instruments, Technology, and Geo

DESCRIPTION
TABLE OF CONTENTS
METHODOLOGY
DOWNLOAD PDF

High-Throughput Screening (HTS) Market by Instruments (Liquid Handling, Detection, Imaging), Consumables (Reagents, Kits), Software, Services, Technology (Cell-based, High-content, Label-free), Workflow, Application, Competition - Global Forecast to 2031

USD 45.90 BN

MARKET SIZE, 2031

HIGH THROUGHPUT SCREENING MARKET SIZE, SHARE & GROWTH SNAPSHOT

high-throughput-screening-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global high-throughput screening (HTS) market is projected to grow from USD 27.66 billion in 2026 to USD 45.90 billion by 2031, at a CAGR of 10.7% during the forecast period. The market was valued at USD 26.43 billion in 2025. Growth in the high-throughput screening (HTS) market can mainly be attributed to factors such as the growing adoption of open, innovative models in pharmaceutical & biotechnology companies, rising government funding and venture capital investments, increasing R&D spending, and technological advancements in the high-throughput screening (HTS) market.

KEY TAKEAWAYS

BY REGION

By region, North America accounted for the largest share of ~43.0% of the market in 2025.
BY OFFERING

By offering, the products segment accounted for the largest share of ~85.0% of the market in 2025.
BY PRODUCT TYPE

By product type, the reagents, kits, and consumables segment dominated the market, with a share of ~61.0% in 2025.
PRODUCT BY TECHNOLOGY

AI-enabled & computational screening technologies are expected to register the highest CAGR during the forecast period.
PRODUCT BY WORKFLOW

The high-throughput screening segment held the largest share of the HTS market in 2025.
PRODUCT BY END USER

The pharmaceutical & biotechnology companies segment accounted for a larger share of the market in 2025.
SERVICE BY TYPE

The data analysis & informatics services segment is projected to grow at the fastest CAGR during the forecast period.
SERVICE BY END USER

By end user, the pharmaceutical & biotechnology companies segment dominated the market in 2025.
BY APPLICATION

By application, the drug discovery & development segment dominated the market in 2025.
COMPETITIVE LANDSCAPE - KEY PLAYERS

Companies such as Thermo Fisher Scientific, Inc., Danaher Corporation, Agilent Technologies, Inc., and Merck KGaA were identified as the star players in the global HTS market, given their strong market share and product & service footprint.
COMPETITIVE LANDSCAPE - STARTUPS/SMES

Companies such as HighRes Biosolutions, Creative Biolabs, and Axxam S.p.A., among others have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.

The high-throughput screening (HTS) market is expected to expand significantly in the next decade, driven by the need for faster, more scalable drug discovery workflows. Growth is supported by rising pharmaceutical and biotechnology R&D spending, increasing use of outsourced discovery models, and advances in automation, high-content screening, cell-based assays, and AI-enabled data analysis. Wider adoption of 3D cell cultures, organoids, and improved screening platforms is further strengthening market expansion.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The impact of customer-side business trends in the high-throughput screening (HTS) market is shaped by changing drug discovery priorities and research workflow needs. Key trends include the shift toward outsourced and collaborative discovery models, greater use of automated and AI-enabled screening platforms, and growing demand for biologically relevant assays such as cell-based, 3D culture, and organoid-based screening.

high-throughput-screening-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

OPPORTUNITIES

Impact
Level

Increasing adoption of HTS technologies in emerging markets
Growing application of HTS in drug repurposing and personalized medicine

Complexity in data management and analysis

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Growing R&D funding from pharmaceutical companies, biotechnology firms, government agencies, and private investors is a major driver for the high-throughput screening (HTS) market. As drug discovery programs become more complex, companies are investing in automated screening platforms to evaluate larger compound, gene, and cell libraries with better speed and accuracy. Public funding for translational research and academic drug discovery centers is also supporting wider adoption of HTS systems. In parallel, venture capital-backed biotech companies are increasingly using HTS to accelerate target validation and hit identification. These investments are strengthening demand for assay kits, reagents, microplate readers, liquid handlers, imaging systems, and outsourced screening services.

High costs associated with HTS instruments remain a key restraint, especially for small biotechnology firms, academic institutes, and emerging-market laboratories. Advanced platforms such as automated liquid handling systems, high-content imaging systems, robotic workstations, and integrated screening platforms require significant upfront capital investment. In addition, maintenance, software licenses, assay optimization, skilled labor, and facility requirements add to the total cost of ownership. These cost barriers often delay purchasing decisions or limit adoption to well-funded pharmaceutical companies and large research centers. As a result, some users prefer outsourcing HTS services rather than building a comprehensive in-house screening infrastructure.

Emerging markets present strong growth opportunities for HTS product and service providers due to expanding pharmaceutical R&D, growing CRO activity, and increasing government support for life science research. Countries across the Asia Pacific, Latin America, and the Middle East are investing in drug discovery infrastructure, academic screening centers, and biotechnology innovation hubs. The rising presence of local and global CROs is also increasing demand for microplate-based screening, assay kits, automation systems, and data analysis tools. Cost-efficient research operations in these regions make them attractive for outsourced discovery programs. As HTS awareness and infrastructure improve, emerging markets are expected to become important revenue pockets for both product suppliers and screening service providers.

The complexity of data management and analysis is a major challenge in the HTS market, as modern screening workflows generate large volumes of multidimensional data. High-content imaging, cell-based assays, label-free detection, and 3D models produce complex datasets that require advanced informatics, image analysis, statistical tools, and biological interpretation. Many laboratories face difficulties in integrating data from different instruments, software platforms, assay formats, and screening sites. Poor data quality, false positives, assay variability, and lack of standardized analysis workflows can affect hit selection and downstream decision-making. This creates a growing need for skilled bioinformaticians, robust software platforms, and AI-enabled analytics to improve the reliability of HTS outputs.

HIGH THROUGHPUT SCREENING MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY	USE CASE DESCRIPTION	BENEFITS
	Partnered with DyNAbind to deploy a fragment-based DNA-encoded Chemical Library (DEL) platform, enabling simultaneous screening of over 370,000 fragment pairs against novel protein targets.	Enabled access to large-scale DEL screening without requiring dedicated HTS infrastructure; broadened tractable chemical space for novel and difficult targets, delivering more trustworthy hit identification results with significantly reduced false-positive rates.
	Implemented a cell painting-based phenotypic HTS platform integrated with machine learning to predict compound bioactivity across large libraries without running individual biochemical assays for each target \| AstraZeneca researchers screened a structurally diverse set of 8,300 compounds in a cell painting assay, then trained ML models on single-point bioactivity data from their internal HTS database to predict and rank compound activity across multiple targets.	The approach enabled prioritization of compounds for probability of activity, effectively using one high-content imaging screen to generate predictions across an entire compound library of ~1 million compounds—substantially reducing the number of individual assays required.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The ecosystem consists of pharmaceutical & biotechnology companies (primary customers), HTS service providers (screening services), instrument & reagent suppliers, academic & research institutions, technology providers, data management & analysis providers, regulatory authorities (ensuring compliance and safety), and collaborative networks promoting knowledge sharing and collaboration. These stakeholders interact and collaborate to drive advancements in HTS technologies, enhance drug discovery processes, and develop new therapeutics.

high-throughput-screening-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

high-throughput-screening-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

In 2025, the products segment accounted for the largest share of the high-throughput screening (HTS) market. This dominance is mainly driven by the recurring use of assay kits, reagents, consumables, microplates, compound libraries, instruments, automation platforms, and software across HTS workflows. Since most screening programs require repeated product consumption from assay setup to hit confirmation, products continue to generate a larger revenue base than services.

The reagents, kits, and consumables segment held the largest share of the HTS products market in 2025. These products are essential for conducting biochemical assays, cell-based assays, detection reactions, sample preparation, compound screening, and secondary validation. Their recurring usage, broad application across multiple assay formats, and high replacement demand make them the most commercially significant product category in HTS workflows.

Cell-based screening technologies held the largest share of the HTS products market by technology in 2025. These technologies are widely used because they provide more biologically relevant insights than traditional biochemical assays by assessing compound effects in living cells. The growing use of phenotypic screening, high-content imaging, 3D cell models, organoids, and disease-relevant cellular assays further supports the dominance of cell-based screening in modern drug discovery.

Primary screening services accounted for the largest share of the HTS services market in 2025. This is because primary screening forms the core outsourced activity in early-stage discovery, where large compound, cell, or gene libraries are screened to identify initial hits. Pharmaceutical and biotechnology companies increasingly use specialized service providers to access automated platforms, assay expertise, compound libraries, and faster screening capacity without heavy in-house infrastructure investment.

The drug discovery & development segment accounted for the largest share of the HTS market in 2025. HTS is extensively used by pharmaceutical and biotechnology companies to screen large compound libraries, identify hits, validate targets, and support lead optimization. Its ability to improve screening speed, reduce early-stage discovery timelines, and support decision-making across small-molecule, biologics, and precision medicine pipelines makes drug discovery & development the leading application area.

REGION

Asia Pacific to be fastest-growing region in global high-throughput screening (HTS) market during forecast period

The Asia Pacific region is expected to record the fastest growth in the high-throughput screening (HTS) market during the forecast period. Growth is supported by expanding pharmaceutical and biotechnology R&D activity, increasing CRO presence, and rising investments in drug discovery infrastructure across China, India, Japan, South Korea, and other emerging markets. The region is also benefiting from cost-efficient research operations, growing biotech start-up activity, and increasing adoption of automated screening platforms, microplate-based assays, and advanced analytical tools. In addition, collaborations between global pharmaceutical companies, local CROs, academic institutes, and government-backed research organizations are helping strengthen HTS capabilities across the region.

high-throughput-screening-market Region

HIGH THROUGHPUT SCREENING MARKET: COMPANY EVALUATION MATRIX

The company evaluation matrix provides information on the top 21 players offering HTS-related products & services and outlines each vendor's performance. In the HTS market, Thermo Fisher Scientific Inc. (US) leads with a strong market presence and a wide product & service portfolio. Eppendorf SE (Germany) (Emerging Leader) is gaining traction, with sustainable revenue growth and expanding geographic presence.

high-throughput-screening-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

Thermo Fisher Scientific Inc. (US)
Agilent Technologies, Inc. (US)
Merck KGaA (Germany)
Danaher Corporation (US)
Revvity, Inc. (US)
Tecan Group Ltd. (Switzerland)
Bio-Rad Laboratories, Inc. (US)
Corning Incorporated (US),
Mettler-Toledo International Inc. (US)
Lonza (Switzerland)
Waters Corporation (US)
Sartorius AG (Germany)
Eppendorf SE (Germany)
Porvair Plc (UK)
Greiner AG (Austria)
Charles River Laboratories (US)
Eurofins Scientific (Europe)

MARKET SCOPE

REPORT METRIC	DETAILS
Market Size in 2025 (Value)	USD 26.43 Billion
Market Forecast in 2026 (Value)	USD 27.66 Billion
Market Forecast in 2031 (Value)	USD 45.90 Billion
Growth Rate	CAGR of 10.7% from 2026–2031
Years Considered	2024–2031
Base Year	2025
Forecast Period	2026–2031
Units Considered	Value (USD Million/Billion)
Report Coverage	Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Segments Covered	By Offering: Products Services Products by Type: Instruments; Reagents Kits and Consumables; Software & Informatics; Services Products by Technology: Biochemical Screening Technologies Cell-based Screening Technologies High-content Screening (HCS) Technologies Label-free Screening Technologies Microfluidic & Miniaturized Screening Technologies 3D Cell Culture & Advanced Cellular Model Technologies Ultra-high-throughput & Automation Technologies AI-enabled & Computational Screening Technologies Products by Workflow: Assay Development & Optimization Compound Library Preparation High-throughput Screening Data Analysis & Hit Identification Hit Confirmation Hit Validation & Characterization Products by End User: Pharmaceutical & Biotechnology Companies CROs & CDMOs Academic & Research Institutes Other End Users Services by Type: Assay Development & Optimization Services Compound Library Management Services Primary Screening Services Secondary Screening & Hit Confirmation Services Hit Validation & Characterization Services Data Analysis & Informatics Services Other Services Service by End User: Pharmaceutical & Biotechnology Companies Academic & Research Institutes Other End Users By Application: Drug Discovery & Development Basic Research & Functional Genomics Toxicology & Safety Screening Precision Medicine & Biomarker Discovery Stem Cell & Regenerative Medicine Research Other Applications
Regions Covered	North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

WHAT IS IN IT FOR YOU: HIGH THROUGHPUT SCREENING MARKET REPORT CONTENT GUIDE

high-throughput-screening-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST	CUSTOMIZATION DELIVERED	VALUE ADDS
HTS Products Market in North America & Europe	Country-level market estimation & forecast of HTS instruments, reagents & consumables, and software across key European markets Market growth trends and adoption analysis by product type Detailed company profiles of key regional competitors	Enables prioritized market entry and expansion planning Helps assess regional demand dynamics and identify high-growth product categories
Outsourced HTS Services Opportunity by Customer Type	Custom assessment of demand for outsourced HTS services across big pharma, emerging biotech, academic research centers, CROs, and government-funded institutes The analysis covered primary screening, assay development, secondary screening, hit confirmation, data analysis, and hit validation services	Helps service providers identify the most attractive customer groups, define service bundles, and prioritize commercial efforts toward customers with limited in-house screening infrastructure

RECENT DEVELOPMENTS

April 2026 : Agilent Technologies, Inc. (US) launched the BioTek Cytation 9 Cell Imaging Multimode Reader, designed to support applications such as phenotypic screening, cellular assays, and drug discovery research.
February 2026 : Revvity launched the Opera Phenix OptIQ high-content screening system, EnVision Nexus One multimode plate reader, and the AssayMate workstation to expand the company’s portfolio across high-content imaging, detection, automation, and screening workflows for drug discovery applications.
January 2026 : Molecular Devices, LLC (US) partnered with Automata to integrate its imaging, microplate reader, and high-content screening systems with Automata’s LINQ platform, enabling more connected and AI-ready laboratory workflows.

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

MARKET OVERVIEW

Unlock growth by leveraging HTS technologies amidst rising investments and emerging market opportunities.

4.2.1.1

GROWING ADOPTION OF OPEN INNOVATIVE MODELS

4.2.1.2

TECHNOLOGICAL ADVANCEMENTS

4.2.1.3

GROWING R&D FUNDING AND INCREASING PUBLIC & PRIVATE INVESTMENTS

4.2.1.4

GROWING ADOPTION OF LAB AUTOMATION & ROBOTIC SCREENING PLATFORMS

4.2.1.5

INCREASING OUTSOURCING OF SCREENING ACTIVITIES TO CROS & CDMOS

4.2.2.1

HIGH COSTS ASSOCIATED WITH HTS INSTRUMENTS

4.2.2.2

COMPLEXITY IN ASSAY DEVELOPMENT AND VALIDATION

4.2.3.1

INCREASING ADOPTION OF HTS TECHNOLOGIES IN EMERGING MARKETS

4.2.3.2

GROWING APPLICATION OF HTS IN DRUG REPURPOSING AND PERSONALIZED MEDICINE

4.2.3.3

EXPANSION OF CRISPR, RNAI, AND FUNCTIONAL GENOMICS SCREENING

4.2.4.1

COMPLEXITY IN DATA MANAGEMENT AND ANALYSIS

4.3

UNMET NEEDS & WHITE SPACES

4.4

INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES

4.5

STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

INDUSTRY TRENDS

Navigate competitive dynamics and economic shifts shaping high-throughput screening's future landscape.

5.1

PORTER’S FIVE FORCES ANALYSIS

5.1.1

INTENSITY OF COMPETITIVE RIVALRY

5.1.2

BARGAINING POWER OF SUPPLIERS

5.1.3

BARGAINING POWER OF BUYERS

5.1.4

THREAT OF SUBSTITUTES

5.1.5

THREAT OF NEW ENTRANTS

5.2

MACROECONOMIC OUTLOOK

5.2.2

GDP TRENDS & FORECAST

5.2.3

TRENDS IN GLOBAL HIGH-THROUGHPUT SCREENING INDUSTRY

5.5.1

AVERAGE SELLING PRICE TREND OF HTS PRODUCTS, BY KEY PLAYER, 2023–2025

5.5.2

AVERAGE SELLING PRICE TREND OF HTS PRODUCTS, BY REGION, 2023–2025

5.6.1

IMPORT SCENARIO (HS CODE 902730 & 902781)

5.6.2

EXPORT SCENARIO (HS CODE 902730& 902781)

5.7

KEY CONFERENCES & EVENTS, 2026–2027

5.8

TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES

5.9

INVESTMENT & FUNDING SCENARIO

5.10

IMPACT OF 2025 US TARIFFS ON HIGH-THROUGHPUT SCREENING (HTS) MARKET

5.10.3

PRICE IMPACT ANALYSIS

5.10.4

IMPACT ON COUNTRIES/REGIONS

5.10.5

IMPACT ON END-USE INDUSTRIES

5.10.5.1

PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

5.10.5.3

ACADEMIC & RESEARCH INSTITUTES

TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, AND INNOVATIONS

AI-driven innovations revolutionize high-throughput screening, reshaping patent landscapes and market readiness.

109

6.1

TECHNOLOGICAL ANALYSIS

6.1.1

KEY EMERGING TECHNOLOGIES

6.1.1.1

HIGH-CONTENT SCREENING

6.1.1.2

LABEL-FREE DETECTION

6.1.2

COMPLEMENTARY TECHNOLOGIES

6.1.2.1

LABORATORY AUTOMATION & ROBOTIC INTEGRATION

6.1.2.2

MASS SPECTROMETRY

6.1.3

ADJACENT TECHNOLOGIES

6.1.3.1

FRAGMENT-BASED DRUG DISCOVERY

6.1.3.2

BIOINFORMATICS & CHEMINFORMATICS

6.2

TECHNOLOGY/PRODUCT ROADMAP

6.3.1

TOP APPLICANTS/OWNERS (COMPANIES) FOR HIGH-THROUGHPUT SCREENING PATENTS, 2015–2025

6.5

IMPACT OF AI/GEN AI ON HIGH-THROUGHPUT SCREENING (HTS) MARKET

6.5.1

BEST PRACTICES IN HTS WORKFLOW

6.5.2

CASE STUDIES OF AI IMPLEMENTATION IN HIGH-THROUGHPUT SCREENING (HTS) MARKET

6.5.3

INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS

6.5.4

CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN HIGH-THROUGHPUT SCREENING (HTS) MARKET

SUSTAINABILITY & REGULATORY LANDSCAPE

Navigate global sustainability regulations and compliance for strategic advantage and eco-certification success.

120

7.1

REGIONAL REGULATIONS & COMPLIANCE

7.1.1

REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

7.2

SUSTAINABILITY INITIATIVES

7.3

SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES

7.4

CERTIFICATIONS, LABELING, AND ECO-STANDARDS

CUSTOMER LANDSCAPE & BUYER BEHAVIOR

Unlock strategic insights into buyer dynamics and unmet needs driving market profitability.

125

8.1

DECISION-MAKING PROCESS

8.2

BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA

8.2.1

KEY STAKEHOLDERS IN BUYING PROCESS

8.2.2

KEY BUYING CRITERIA, BY END USER

8.3

ADOPTION BARRIERS & INTERNAL CHALLENGES

8.4

UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES

HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 15 Data Tables

129

9.2.1

RECURRING CONSUMABLES DEMAND, AUTOMATION UPGRADES, AND ADVANCED SCREENING PLATFORMS TO DRIVE MARKET GROWTH

9.3.1

RISING OUTSOURCING OF ASSAY DEVELOPMENT, PRIMARY SCREENING, AND DATA ANALYSIS TO DRIVE GROWTH OF HTS SERVICES MARKET

HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 232 Data Tables

138

10.2

REAGENTS, KITS, AND CONSUMABLES

10.2.1

SCREENING ASSAY KITS

10.2.1.1

CELL-BASED ASSAYS

10.2.1.1.1

CELL VIABILITY ASSAYS

10.2.1.1.2

CYTOTOXICITY ASSAYS

10.2.1.1.3

REPORTER GENE ASSAYS

10.2.1.1.4

OTHER CELL-BASED ASSAYS

10.2.1.2

BIOCHEMICAL ASSAYS

10.2.1.2.3

BINDING ASSAYS

10.2.1.2.4

OTHER BIOCHEMICAL ASSAYS

10.2.1.3

OTHER ASSAYS & KITS

10.2.2

BIOLOGICAL & CELL CULTURE REAGENTS

10.2.2.1

RISING USE OF DISEASE-RELEVANT CELLULAR MODELS TO STRENGTHEN DEMAND FOR BIOLOGICAL AND CELL CULTURE REAGENTS

10.2.3

COMPOUND LIBRARIES

10.2.3.1

EXPANSION OF FOCUSED AND REPURPOSE LIBRARIES TO SUPPORT COMPOUND LIBRARY DEMAND

10.2.4

DETECTION REAGENTS

10.2.4.1

INCREASING ADOPTION OF FLUORESCENCE, LUMINESCENCE, AND BIOMARKER-BASED READOUTS TO DRIVE DETECTION REAGENT USE

10.2.5

3D CELL CULTURE PRODUCTS

10.2.5.1

SCAFFOLD-BASED 3D CELL CULTURE PRODUCTS

10.2.5.1.1

RISING DEMAND FOR MATRIX-SUPPORTED DISEASE MODELS TO DRIVE SCAFFOLD-BASED 3D CULTURE PRODUCT GROWTH

10.2.5.2

SCAFFOLD-FREE 3D CELL CULTURE PRODUCTS

10.2.5.2.1

INCREASING USE OF SPHEROID-BASED SCREENING TO SUPPORT SCAFFOLD-FREE 3D CULTURE PRODUCT ADOPTION

10.2.5.3

OTHER 3D CELL CULTURE PRODUCTS

10.2.6

OTHER HTS CONSUMABLES

10.3.1

DETECTION & IMAGING SYSTEMS

10.3.1.1

MICROPLATE READERS

10.3.1.1.1

GROWING USE OF MULTIPLEXED BIOCHEMICAL AND CELL-BASED ASSAYS TO SUPPORT MICROPLATE READER DEMAND

10.3.1.2

HIGH-CONTENT SCREENING (HCS) & IMAGING SYSTEMS

10.3.1.2.1

INCREASING ADOPTION OF PHENOTYPIC SCREENING AND AI-BASED CELLULAR ANALYSIS TO DRIVE GROWTH OF HCS SYSTEMS

10.3.1.3

CELL ANALYSIS SYSTEMS

10.3.1.3.1

GROWING USE OF CELL-BASED SCREENING AND FUNCTIONAL BIOLOGY ASSAYS TO STRENGTHEN DEMAND FOR CELL ANALYSIS SYSTEMS

10.3.1.4

LABEL-FREE DETECTION SYSTEMS

10.3.1.4.1

RISING NEED FOR REAL-TIME BIOMOLECULAR INTERACTION ANALYSIS TO SUPPORT ADOPTION OF LABEL-FREE DETECTION SYSTEMS

10.3.1.5

MICROFLUIDIC & MINIATURIZED SCREENING SYSTEMS

10.3.1.5.1

ASSAY MINIATURIZATION TO DRIVE ADOPTION OF MICROFLUIDIC SCREENING SYSTEMS

10.3.2

LIQUID HANDLING & AUTOMATION SYSTEMS

10.3.2.1

INCREASING ASSAY MINIATURIZATION AND WORKFLOW STANDARDIZATION TO DRIVE GROWTH OF LIQUID HANDLING & AUTOMATION SYSTEMS

10.3.3

ROBOTIC HTS PLATFORMS & AUTOMATED WORKFLOW SYSTEMS

10.3.3.1

RISING DEPLOYMENT OF END-TO-END LABORATORY AUTOMATION SYSTEMS TO ACCELERATE ROBOTIC HTS PLATFORM ADOPTION

10.3.4

OTHER HTS INSTRUMENTS

10.4

SOFTWARE & INFORMATICS

10.4.1

BIOINFORMATICS TOOLS TO HELP TURN RAW DATA INTO MEANINGFUL INSIGHTS

HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 50 Data Tables

238

11.2

CELL-BASED SCREENING TECHNOLOGIES

11.2.1

INCREASING ADOPTION OF PHYSIOLOGICALLY RELEVANT PHENOTYPIC SCREENING WORKFLOWS TO STRENGTHEN CELL-BASED TECHNOLOGY DEMAND

11.3

ULTRA-HIGH-THROUGHPUT & AUTOMATION TECHNOLOGIES

11.3.1

GROWING DEMAND FOR SCALABLE ROBOTIC INFRASTRUCTURE & INTEGRATED AUTOMATION PLATFORMS TO SUPPORT MARKET GROWTH

11.4

HIGH-CONTENT SCREENING (HCS) TECHNOLOGIES

11.4.1

RISING ADOPTION OF AI-POWERED PHENOTYPIC IMAGING AND MULTIPARAMETRIC CELLULAR PROFILING TO ACCELERATE HCS TECHNOLOGY GROWTH

11.5

BIOCHEMICAL SCREENING TECHNOLOGIES

11.5.1

CONTINUED EXPANSION OF TARGET-BASED DRUG DISCOVERY PROGRAMS TO SUSTAIN BIOCHEMICAL SCREENING PRODUCT DEMAND

11.6

3D CELL CULTURE & ADVANCED CELLULAR MODEL TECHNOLOGIES

11.6.1

RISING ADOPTION OF ORGANOIDS, SPHEROIDS, AND TISSUE-LIKE SCREENING SYSTEMS TO ACCELERATE 3D CELLULAR TECHNOLOGY GROWTH

11.7

LABEL-FREE SCREENING TECHNOLOGIES

11.7.1

INCREASING USE OF REAL-TIME BINDING KINETICS AND BIOPHYSICAL PROFILING TO SUPPORT LABEL-FREE SCREENING ADOPTION

11.8

OTHER HTS TECHNOLOGIES

HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 43 Data Tables

264

12.2.1

LARGE-SCALE COMPOUND SCREENING REQUIREMENTS TO SUSTAIN PRODUCT DEMAND ACROSS PRIMARY HTS WORKFLOWS

12.3

ASSAY DEVELOPMENT & OPTIMIZATION

12.3.1

RISING NEED FOR ROBUST, MINIATURIZED, AND AUTOMATION-COMPATIBLE ASSAYS TO SUPPORT ASSAY DEVELOPMENT PRODUCT DEMAND

12.4

HIT CONFIRMATION/SECONDARY SCREENING

12.4.1

RISING FOCUS ON HIT QUALITY ASSESSMENT AND FALSE-POSITIVE REDUCTION TO SUPPORT SECONDARY SCREENING PRODUCT DEMAND

12.5

DATA ANALYSIS & HIT IDENTIFICATION

12.5.1

INCREASING INTEGRATION OF AI-DRIVEN ANALYTICS AND IMAGE-BASED SCREENING DATA TO ACCELERATE HIT IDENTIFICATION WORKFLOWS

12.6

COMPOUND LIBRARY PREPARATION

12.6.1

EXPANSION OF LARGE-SCALE AND FOCUSED SCREENING LIBRARIES TO STRENGTHEN DEMAND FOR COMPOUND PREPARATION PRODUCTS

12.7

HIT VALIDATION & CHARACTERIZATION

12.7.1

GROWING FOCUS ON PHENOTYPIC CHARACTERIZATION WORKFLOWS TO DRIVE HIT VALIDATION PRODUCT DEMAND

HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 29 Data Tables

286

13.2

PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

13.2.1

SUSTAINED BIOPHARMA R&D INVESTMENT AND AUTOMATION-LED DRUG DISCOVERY TO DRIVE HTS PRODUCT ADOPTION

13.3.1

RISING DISCOVERY OUTSOURCING AND CRO PLATFORM EXPANSION TO ACCELERATE HTS PRODUCT DEMAND

13.4

ACADEMIC & RESEARCH INSTITUTES

13.4.1

PUBLIC RESEARCH FUNDING AND TRANSLATIONAL BIOLOGY PROGRAMS TO SUPPORT HTS PRODUCT UPTAKE IN RESEARCH INSTITUTES

HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 50 Data Tables

301

14.2

PRIMARY SCREENING SERVICES

14.2.1

RISING HIGH-VOLUME SCREENING REQUIREMENTS TO DRIVE GROWTH OF PRIMARY HTS SCREENING SERVICES

14.3

ASSAY DEVELOPMENT & OPTIMIZATION SERVICES

14.3.1

INCREASING DEMAND FOR CUSTOMIZED AND MINIATURIZED ASSAYS TO SUPPORT ASSAY DEVELOPMENT SERVICE ADOPTION

14.4

SECONDARY SCREENING & HIT CONFIRMATION SERVICES

14.4.1

INCREASING EMPHASIS ON HIT VALIDATION AND SELECTIVITY ASSESSMENT TO SUPPORT SECONDARY SCREENING SERVICES

14.5

HIT VALIDATION & CHARACTERIZATION SERVICES

14.5.1

GROWING NEED FOR MECHANISM-OF-ACTION PROFILING TO STRENGTHEN HIT CHARACTERIZATION SERVICE ADOPTION

14.6

COMPOUND LIBRARY MANAGEMENT SERVICES

14.6.1

EXPANSION OF LARGE-SCALE SCREENING LIBRARIES TO STRENGTHEN DEMAND FOR COMPOUND MANAGEMENT SERVICES

14.7

DATA ANALYSIS & INFORMATICS SERVICES

14.7.1

GROWING ADOPTION OF AI-ENABLED SCREENING ANALYTICS AND IMAGE-BASED DATA INTERPRETATION TO DRIVE HTS INFORMATICS SERVICES GROWTH

HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 22 Data Tables

325

15.2

PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

15.2.1

INCREASING COMPLEXITY OF DRUG DISCOVERY WORKFLOWS TO STRENGTHEN OUTSOURCING OF HTS SERVICES BY PHARMA AND BIOTECH COMPANIES

15.3

ACADEMIC & RESEARCH INSTITUTES

15.3.1

LIMITED IN-HOUSE AUTOMATION CAPACITY TO DRIVE ACADEMIC OUTSOURCING OF HTS SERVICES

HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 43 Data Tables

336

16.2

DRUG DISCOVERY & DEVELOPMENT

16.2.1

INCREASING PHARMACEUTICAL R&D INVESTMENTS AND EXPANSION OF TARGET-BASED AND PHENOTYPIC DRUG DISCOVERY PROGRAMS TO DRIVE MARKET GROWTH

16.3

BASIC RESEARCH & FUNCTIONAL GENOMICS

16.3.1

GROWING ADOPTION OF CRISPR SCREENING, FUNCTIONAL GENOMICS, AND DISEASE PATHWAY CHARACTERIZATION TO DRIVE HTS DEMAND

16.4

TOXICOLOGY & SAFETY SCREENING

16.4.1

INCREASING EMPHASIS ON PREDICTIVE TOXICOLOGY AND REGULATORY PRESSURE TO REDUCE ANIMAL TESTING TO ACCELERATE HTS ADOPTION

16.5

PRECISION MEDICINE & BIOMARKER DISCOVERY

16.5.1

EXPANSION OF BIOMARKER-GUIDED THERAPEUTICS AND PERSONALIZED MEDICINE PIPELINES TO DRIVE RAPID GROWTH IN PRECISION MEDICINE SCREENING APPLICATIONS

16.6

STEM CELL & REGENERATIVE MEDICINE RESEARCH

16.6.1

GROWING DEVELOPMENT OF CELL THERAPIES AND REGENERATIVE MEDICINE PRODUCTS IS SUPPORTING HTS ADOPTION IN STEM CELL RESEARCH

HIGH-THROUGHPUT SCREENING MARKET, BY REGION

Comprehensive coverage of 7 Regions with country-level deep-dive of 16 Countries | 441 Data Tables.

357

17.2.1.1

ADVANCED AUTOMATION, STRONG DRUG DISCOVERY INFRASTRUCTURE, AND AI-ENABLED SCREENING WORKFLOWS TO SUPPORT MARKET GROWTH

17.2.2.1

ACADEMIC SCREENING INFRASTRUCTURE TO SUPPORT MARKET GROWTH

17.3.1.1

INCREASING PRODUCT LAUNCHES AND INVESTMENTS TO BOOST MARKET GROWTH

17.3.2.1

INDUSTRIAL-SCALE SCREENING ACCESS AND ACADEMIC HTS INFRASTRUCTURE TO SUPPORT MARKET

17.3.3.1

LARGE PHARMACEUTICAL R&D EXPENDITURE TO DRIVE MARKET GROWTH

17.3.4.1

FUNCTIONAL GENOMICS AND AUTOMATED SCREENING PLATFORMS TO FUEL GROWTH

17.3.5.1

ACADEMIC SCREENING PLATFORMS, CHEMICAL BIOLOGY NETWORKS, AND ASSAY AUTOMATION TO BOOST MARKET

17.4.1.1

AUTOMATION-LED DRUG DISCOVERY AND CRO-LED SCREENING CAPACITY EXPANSION TO SUPPORT GROWTH OF MARKET

17.4.2.1

ADVANCED SCREENING PLATFORMS AND INTEGRATED DRUG DISCOVERY PARTNERSHIPS TO SUPPORT MARKET GROWTH

17.4.3.1

AUTOMATION-LED CRO EXPANSION AND BIOPHARMA R&D INFRASTRUCTURE GROWTH TO FUEL MARKET

17.4.4.1

ROBOTIC SCREENING INFRASTRUCTURE AND TRANSLATIONAL DRUG DISCOVERY PROGRAMS TO DRIVE MARKET GROWTH

17.4.5.1

AI-ENHANCED SCREENING PLATFORMS AND TRANSLATIONAL R&D COLLABORATIONS TO FAVOR MARKET GROWTH

17.4.6

REST OF ASIA PACIFIC (ROAPAC)

17.5.1.1

AUTOMATED BIOASSAY INFRASTRUCTURE AND DISEASE-FOCUSED DISCOVERY PROGRAMS TO DRIVE GROWTH

17.5.2.1

COST-EFFICIENT DISCOVERY CAPACITY, ANTIMICROBIAL RESEARCH, AND AUTOMATED ASSAY ADOPTION TO DRIVE GROWTH

17.5.3

REST OF LATIN AMERICA

17.6.1.1.1

GROWING PHARMACEUTICALS INDUSTRY TO SUPPORT MARKET GROWTH

17.6.1.2.1

PRECISION MEDICINE INVESTMENT, AUTOMATED LABORATORY INFRASTRUCTURE, AND AI-ENABLED DISCOVERY WORKFLOWS TO BOOST MARKET GROWTH

17.6.1.3

REST OF GCC COUNTRIES

17.6.2

REST OF MIDDLE EAST

17.7.1

INFECTIOUS DISEASE RESEARCH AND SHARED DISCOVERY NETWORKS TO AID MARKET GROWTH

COMPETITIVE LANDSCAPE

Gain insights into strategic moves and market dominance of key HTS players and emerging startups.

565

18.2

KEY PLAYER STRATEGY/RIGHT TO WIN

18.2.1

OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN HIGH-THROUGHPUT SCREENING (HTS) MARKET

18.3

REVENUE ANALYSIS, 2021–2025

18.4

MARKET SHARE ANALYSIS, 2025

18.5

COMPANY EVALUATION QUADRANT: KEY PLAYERS, 2025

18.5.5

COMPANY FOOTPRINT: KEY PLAYERS, 2025

18.5.5.1

COMPANY FOOTPRINT

18.5.5.2

REGION FOOTPRINT

18.5.5.3

OFFERING FOOTPRINT

18.5.5.4

PRODUCT TYPE FOOTPRINT

18.5.5.5

APPLICATION FOOTPRINT

18.6

COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025

18.6.1

PROGRESSIVE COMPANIES

18.6.2

RESPONSIVE COMPANIES

18.6.5

COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025

18.6.5.1

DETAILED LIST OF KEY STARTUPS/SMES

18.6.5.2

COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES

18.7

COMPANY VALUATION & FINANCIAL METRICS

18.8

BRAND/PRODUCT/SERVICE COMPARISON

18.9

COMPETITIVE SCENARIO

COMPANY PROFILES

In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)

587

19.1.1

THERMO FISHER SCIENTIFIC INC.

19.1.1.1

BUSINESS OVERVIEW

19.1.1.2

PRODUCTS & SERVICES OFFERED

19.1.1.3

RECENT DEVELOPMENTS

19.1.1.3.1

PRODUCT LAUNCHES

19.1.1.4.2

STRATEGIC CHOICES

19.1.1.4.3

WEAKNESSES & COMPETITIVE THREATS

19.1.2

DANAHER CORPORATION

19.1.4

AGILENT TECHNOLOGIES, INC.

19.1.7

BIO-RAD LABORATORIES, INC.

19.1.8

CORNING INCORPORATED

19.1.9

METTLER-TOLEDO INTERNATIONAL INC.

19.1.11

WATERS CORPORATION

19.1.16

CHARLES RIVER LABORATORIES

19.1.17

EUROFINS SCIENTIFIC

19.1.19

AURORA BIOMED INC.

19.1.20

GILSON INCORPORATED

19.1.21

BRAND GMBH + CO KG

19.2.2

DIANA BIOTECHNOLOGIES, A.S.

19.2.4

HIGHRES BIOSOLUTIONS

19.2.7

SYGNATURE DISCOVERY LIMITED

RESEARCH METHODOLOGY

695

20.1.1.1

KEY SECONDARY SOURCES

20.1.1.2

KEY DATA FROM SECONDARY RESEARCH

20.1.2.1

KEY PRIMARY PARTICIPANTS

20.1.2.2

BREAKDOWN OF PRIMARY INTERVIEWS

20.1.2.3

KEY DATA FROM PRIMARY SOURCES

20.2

MARKET SIZE ESTIMATION

20.2.1

GLOBAL HIGH-THROUGHPUT SCREENING MARKET ESTIMATION, 2025

20.2.1.1

APPROACH 1: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (BOTTOM-UP)

20.2.1.2

APPROACH 2: PRIMARY RESEARCH

20.2.1.2.1

KEY INDUSTRY INSIGHTS

20.2.1.3

APPROACH 3: MNM REPOSITORY ANALYSIS

20.2.2

SEGMENTAL MARKET SIZE ESTIMATION, 2025

20.3

MARKET GROWTH RATE PROJECTIONS

20.5

RESEARCH ASSUMPTIONS

20.6

RESEARCH LIMITATIONS AND RISK ASSESSMENT

21.2

KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL

21.3

CUSTOMIZATION OPTIONS

TABLE 1

HIGH-THROUGHPUT SCREENING (HTS) MARKET: INCLUSIONS & EXCLUSIONS

TABLE 2

HIGH-THROUGHPUT SCREENING (HTS) MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS

TABLE 3

HIGH-THROUGHPUT SCREENING (HTS) MARKET: IMPACT OF PORTER’S FIVE FORCES

TABLE 4

HIGH-THROUGHPUT SCREENING (HTS) MARKET: ROLE IN ECOSYSTEM

TABLE 5

AVERAGE SELLING PRICE TREND OF HTS PRODUCTS, BY KEY PLAYER, 2023–2025 (USD)

TABLE 6

AVERAGE SELLING PRICE TREND OF HTS PRODUCTS, BY REGION, 2023–2025 (USD)

TABLE 7

IMPORT VALUE FOR HS CODE 902730, 2021–2025 (USD THOUSAND)

TABLE 8

IMPORT VOLUME FOR HS CODE 902730, 2021–2025 (TONS)

TABLE 9

IMPORT VALUE FOR HS CODE 902781, 2022–2025 (USD THOUSAND)

TABLE 10

IMPORT VOLUME FOR HS CODE 902781, 2022–2025 (UNITS)

TABLE 11

EXPORT VALUE FOR HS CODE 902730, BY COUNTRY, 2021–2025 (USD THOUSAND)

TABLE 12

EXPORT VOLUME FOR HS CODE 902730, BY COUNTRY, 2021–2025 (TONS)

TABLE 13

EXPORT VALUE FOR HS CODE 902781, 2022–2025 (USD THOUSAND)

TABLE 14

EXPORT VOLUME FOR HS CODE 902781, 2022–2025 (UNITS)

TABLE 15

HIGH-THROUGHPUT SCREENING (HTS) MARKET: KEY CONFERENCES & EVENTS, 2026–2027

TABLE 16

US-ADJUSTED RECIPROCAL TARIFF RATES

TABLE 17

HIGH-THROUGHPUT SCREENING (HTS) MARKET: INDICATIVE LIST OF PATENTS, 2026

TABLE 18

CASE STUDIES OF AI IMPLEMENTATION IN HIGH-THROUGHPUT SCREENING (HTS) MARKET

TABLE 19

CLIENT’S READINESS TO ADOPT GENERATIVE AI IN HIGH-THROUGHPUT SCREENING

TABLE 20

NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 21

EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 22

ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 23

REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 24

US FOOD AND DRUG ADMINISTRATION: MEDICAL DEVICE CLASSIFICATION

TABLE 25

US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS

TABLE 26

INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%)

TABLE 27

KEY BUYING CRITERIA, BY END USER

TABLE 28

HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)

TABLE 29

HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 30

NORTH AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 31

EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 32

ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 33

LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 34

MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 35

GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 36

HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 37

NORTH AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 38

EUROPE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 39

ASIA PACIFIC: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 40

LATIN AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 41

MIDDLE EAST: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 42

GCC COUNTRIES: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 43

HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 44

HTS REAGENTS, KITS, AND CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 45

NORTH AMERICA: HTS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 46

EUROPE: HTS REAGENTS, KITS, AND CONSUMABLES MARKET, 2024–2031 (USD MILLION)

TABLE 47

ASIA PACIFIC: HTS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 48

LATIN AMERICA: HTS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 49

MIDDLE EAST: HTS REAGENTS, KITS, AND CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 50

GCC COUNTRIES: HTS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 51

HTS REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 52

SCREENING ASSAY KITS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 53

NORTH AMERICA: SCREENING ASSAY KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 54

EUROPE: SCREENING ASSAY KITS MARKET, 2024–2031 (USD MILLION)

TABLE 55

ASIA PACIFIC: SCREENING ASSAY KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 56

LATIN AMERICA: SCREENING ASSAY KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 57

MIDDLE EAST: SCREENING ASSAY KITS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 58

GCC COUNTRIES: SCREENING ASSAY KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 59

SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 60

CELL-BASED ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 61

NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 62

EUROPE: CELL-BASED ASSAYS MARKET, 2024–2031 (USD MILLION)

TABLE 63

ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 64

LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 65

MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 66

GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 67

CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 68

CELL VIABILITY ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 69

NORTH AMERICA: CELL VIABILITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 70

EUROPE: CELL VIABILITY ASSAYS MARKET, 2024–2031 (USD MILLION)

TABLE 71

ASIA PACIFIC: CELL VIABILITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 72

LATIN AMERICA: CELL VIABILITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 73

MIDDLE EAST: CELL VIABILITY ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 74

GCC COUNTRIES: CELL VIABILITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 75

CYTOTOXICITY ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 76

NORTH AMERICA: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 77

EUROPE: CYTOTOXICITY ASSAYS MARKET, 2024–2031 (USD MILLION)

TABLE 78

ASIA PACIFIC: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 79

LATIN AMERICA: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 80

MIDDLE EAST: CYTOTOXICITY ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 81

GCC COUNTRIES: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 82

REPORTER GENE ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 83

NORTH AMERICA: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 84

EUROPE: REPORTER GENE ASSAYS MARKET, 2024–2031 (USD MILLION)

TABLE 85

ASIA PACIFIC: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 86

LATIN AMERICA: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 87

MIDDLE EAST: REPORTER GENE ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 88

GCC COUNTRIES: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 89

OTHER CELL-BASED ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 90

NORTH AMERICA: OTHER CELL-BASED ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 91

EUROPE: OTHER CELL-BASED ASSAYS MARKET, 2024–2031 (USD MILLION)

TABLE 92

ASIA PACIFIC: OTHER CELL-BASED ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 93

LATIN AMERICA: OTHER CELL-BASED ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 94

MIDDLE EAST: OTHER CELL-BASED ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 95

GCC COUNTRIES: OTHER CELL-BASED ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 96

BIOCHEMICAL ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 97

NORTH AMERICA: BIOCHEMICAL ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 98

EUROPE: BIOCHEMICAL ASSAYS MARKET, 2024–2031 (USD MILLION)

TABLE 99

ASIA PACIFIC: BIOCHEMICAL ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 100

LATIN AMERICA: BIOCHEMICAL ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 101

MIDDLE EAST: BIOCHEMICAL ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 102

GCC COUNTRIES: BIOCHEMICAL ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 103

BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 104

ENZYME ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 105

NORTH AMERICA: ENZYME ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 106

EUROPE: ENZYME ASSAYS MARKET, 2024–2031 (USD MILLION)

TABLE 107

ASIA PACIFIC: ENZYME ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 108

LATIN AMERICA: ENZYME ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 109

MIDDLE EAST: ENZYME ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 110

GCC COUNTRIES: ENZYME ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 111

KINASE ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 112

NORTH AMERICA: KINASE ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 113

EUROPE: KINASE ASSAYS MARKET, 2024–2031 (USD MILLION)

TABLE 114

ASIA PACIFIC: KINASE ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 115

LATIN AMERICA: KINASE ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 116

MIDDLE EAST: KINASE ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 117

GCC COUNTRIES: KINASE ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 118

BINDING ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 119

NORTH AMERICA: BINDING ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 120

EUROPE: BINDING ASSAYS MARKET, 2024–2031 (USD MILLION)

TABLE 121

ASIA PACIFIC: BINDING ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 122

LATIN AMERICA: BINDING ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 123

MIDDLE EAST: BINDING ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 124

GCC COUNTRIES: BINDING ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 125

OTHER BIOCHEMICAL ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 126

NORTH AMERICA: OTHER BIOCHEMICAL ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 127

EUROPE: OTHER BIOCHEMICAL ASSAYS MARKET, 2024–2031 (USD MILLION)

TABLE 128

ASIA PACIFIC: OTHER BIOCHEMICAL ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 129

LATIN AMERICA: OTHER BIOCHEMICAL ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 130

MIDDLE EAST: OTHER BIOCHEMICAL ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 131

GCC COUNTRIES: OTHER BIOCHEMICAL ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 132

OTHER ASSAYS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 133

NORTH AMERICA: OTHER ASSAYS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 134

EUROPE: OTHER ASSAYS & KITS MARKET, 2024–2031 (USD MILLION)

TABLE 135

ASIA PACIFIC: OTHER ASSAYS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 136

LATIN AMERICA: OTHER ASSAYS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 137

MIDDLE EAST: OTHER ASSAYS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 138

GCC COUNTRIES: OTHER ASSAYS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 139

BIOLOGICAL & CELL CULTURE REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 140

NORTH AMERICA: BIOLOGICAL & CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 141

EUROPE: BIOLOGICAL & CELL CULTURE REAGENTS MARKET, 2024–2031 (USD MILLION)

TABLE 142

ASIA PACIFIC: BIOLOGICAL & CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 143

LATIN AMERICA: BIOLOGICAL & CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 144

MIDDLE EAST: BIOLOGICAL & CELL CULTURE REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 145

GCC COUNTRIES: BIOLOGICAL & CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 146

COMPOUND LIBRARIES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 147

NORTH AMERICA: COMPOUND LIBRARIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 148

EUROPE: COMPOUND LIBRARIES MARKET, 2024–2031 (USD MILLION)

TABLE 149

ASIA PACIFIC: COMPOUND LIBRARIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 150

LATIN AMERICA: COMPOUND LIBRARIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 151

MIDDLE EAST: COMPOUND LIBRARIES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 152

GCC COUNTRIES: COMPOUND LIBRARIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 153

DETECTION REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 154

NORTH AMERICA: DETECTION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 155

EUROPE: DETECTION REAGENTS MARKET, 2024–2031 (USD MILLION)

TABLE 156

ASIA PACIFIC: DETECTION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 157

LATIN AMERICA: DETECTION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 158

MIDDLE EAST: DETECTION REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 159

GCC COUNTRIES: DETECTION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 160

3D CELL CULTURE PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 161

NORTH AMERICA: 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 162

EUROPE: 3D CELL CULTURE PRODUCTS MARKET, 2024–2031 (USD MILLION)

TABLE 163

ASIA PACIFIC: 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 164

LATIN AMERICA: 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 165

MIDDLE EAST: 3D CELL CULTURE PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 166

GCC COUNTRIES: 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 167

3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 168

SCAFFOLD-BASED 3D CELL CULTURE PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 169

NORTH AMERICA: SCAFFOLD-BASED 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 170

EUROPE: SCAFFOLD-BASED 3D CELL CULTURE PRODUCTS MARKET, 2024–2031 (USD MILLION)

TABLE 171

ASIA PACIFIC: SCAFFOLD-BASED 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 172

LATIN AMERICA: SCAFFOLD-BASED 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 173

MIDDLE EAST: SCAFFOLD-BASED 3D CELL CULTURE PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 174

GCC COUNTRIES: SCAFFOLD-BASED 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 175

SCAFFOLD-FREE 3D CELL CULTURE PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 176

NORTH AMERICA: SCAFFOLD-FREE 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 177

EUROPE: SCAFFOLD-FREE 3D CELL CULTURE PRODUCTS MARKET, 2024–2031 (USD MILLION)

TABLE 178

ASIA PACIFIC: SCAFFOLD-FREE 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 179

LATIN AMERICA: SCAFFOLD-FREE 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 180

MIDDLE EAST: SCAFFOLD-FREE 3D CELL CULTURE PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 181

GCC COUNTRIES: SCAFFOLD-FREE 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 182

OTHER 3D CELL CULTURE PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 183

NORTH AMERICA: OTHER 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 184

EUROPE: OTHER 3D CELL CULTURE PRODUCTS MARKET, 2024–2031 (USD MILLION)

TABLE 185

ASIA PACIFIC: OTHER 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 186

LATIN AMERICA: OTHER 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 187

MIDDLE EAST: OTHER 3D CELL CULTURE PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 188

GCC COUNTRIES: OTHER 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 189

OTHER HTS CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 190

NORTH AMERICA: OTHER HTS CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 191

EUROPE: OTHER HTS CONSUMABLES MARKET, 2024–2031 (USD MILLION)

TABLE 192

ASIA PACIFIC: OTHER HTS CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 193

LATIN AMERICA: OTHER HTS CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 194

MIDDLE EAST: OTHER HTS CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 195

GCC COUNTRIES: OTHER HTS CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 196

HTS INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 197

NORTH AMERICA: HTS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 198

EUROPE: HTS INSTRUMENTS MARKET, 2024–2031 (USD MILLION)

TABLE 199

ASIA PACIFIC: HTS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 200

LATIN AMERICA: HTS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 201

MIDDLE EAST: HTS INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 202

GCC COUNTRIES: HTS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 203

HTS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 204

DETECTION & IMAGING SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 205

NORTH AMERICA: DETECTION & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 206

EUROPE: DETECTION & IMAGING SYSTEMS MARKET, 2024–2031 (USD MILLION)

TABLE 207

ASIA PACIFIC: DETECTION & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 208

LATIN AMERICA: DETECTION & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 209

MIDDLE EAST: DETECTION & IMAGING SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 210

GCC COUNTRIES: DETECTION & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 211

DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 212

MICROPLATE READERS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 213

NORTH AMERICA: MICROPLATE READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 214

EUROPE: MICROPLATE READERS MARKET, 2024–2031 (USD MILLION)

TABLE 215

ASIA PACIFIC: MICROPLATE READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 216

LATIN AMERICA: MICROPLATE READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 217

MIDDLE EAST: MICROPLATE READERS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 218

GCC COUNTRIES: MICROPLATE READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 219

HIGH-CONTENT SCREENING & IMAGING SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 220

NORTH AMERICA: HIGH-CONTENT SCREENING & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 221

EUROPE: HIGH-CONTENT SCREENING & IMAGING SYSTEMS MARKET, 2024–2031 (USD MILLION)

TABLE 222

ASIA PACIFIC: HIGH-CONTENT SCREENING & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 223

LATIN AMERICA: HIGH-CONTENT SCREENING & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 224

MIDDLE EAST: HIGH-CONTENT SCREENING & IMAGING SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 225

GCC COUNTRIES: HIGH-CONTENT SCREENING & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 226

CELL ANALYSIS SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 227

NORTH AMERICA: CELL ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 228

EUROPE: CELL ANALYSIS SYSTEMS MARKET, 2024–2031 (USD MILLION)

TABLE 229

ASIA PACIFIC: CELL ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 230

LATIN AMERICA: CELL ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 231

MIDDLE EAST: CELL ANALYSIS SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 232

GCC COUNTRIES: CELL ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 233

LABEL-FREE DETECTION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 234

NORTH AMERICA: LABEL-FREE DETECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 235

EUROPE: LABEL-FREE DETECTION SYSTEMS MARKET, 2024–2031 (USD MILLION)

TABLE 236

ASIA PACIFIC: LABEL-FREE DETECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 237

LATIN AMERICA: LABEL-FREE DETECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 238

MIDDLE EAST: LABEL-FREE DETECTION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 239

GCC COUNTRIES: LABEL-FREE DETECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 240

MICROFLUIDIC & MINIATURIZED SCREENING SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 241

NORTH AMERICA: MICROFLUIDIC & MINIATURIZED SCREENING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 242

EUROPE: MICROFLUIDIC & MINIATURIZED SCREENING SYSTEMS MARKET, 2024–2031 (USD MILLION)

TABLE 243

ASIA PACIFIC: MICROFLUIDIC & MINIATURIZED SCREENING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 244

LATIN AMERICA: MICROFLUIDIC & MINIATURIZED SCREENING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 245

MIDDLE EAST: MICROFLUIDIC & MINIATURIZED SCREENING SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 246

GCC COUNTRIES: MICROFLUIDIC & MINIATURIZED SCREENING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 247

LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 248

NORTH AMERICA: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 249

EUROPE: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, 2024–2031 (USD MILLION)

TABLE 250

ASIA PACIFIC: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 251

LATIN AMERICA: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 252

MIDDLE EAST: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 253

GCC COUNTRIES: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 254

ROBOTIC HTS PLATFORMS & AUTOMATED WORKFLOW SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 255

NORTH AMERICA: ROBOTIC HTS PLATFORMS & AUTOMATED WORKFLOW SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 256

EUROPE: ROBOTIC HTS PLATFORMS & AUTOMATED WORKFLOW SYSTEMS MARKET, 2024–2031 (USD MILLION)

TABLE 257

ASIA PACIFIC: ROBOTIC HTS PLATFORMS & AUTOMATED WORKFLOW SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 258

LATIN AMERICA: ROBOTIC HTS PLATFORMS & AUTOMATED WORKFLOW SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 259

MIDDLE EAST: ROBOTIC HTS PLATFORMS & AUTOMATED WORKFLOW SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 260

GCC COUNTRIES: ROBOTIC HTS PLATFORMS & AUTOMATED WORKFLOW SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 261

OTHER HTS INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 262

NORTH AMERICA: OTHER HTS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 263

EUROPE: OTHER HTS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 264

ASIA PACIFIC: OTHER HTS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 265

LATIN AMERICA: OTHER HTS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 266

MIDDLE EAST: OTHER HTS INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 267

GCC COUNTRIES: OTHER HTS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 268

HTS SOFTWARE & INFORMATICS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 269

NORTH AMERICA: HTS SOFTWARE & INFORMATICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 270

EUROPE: HTS SOFTWARE & INFORMATICS MARKET, 2024–2031 (USD MILLION)

TABLE 271

ASIA PACIFIC: HTS SOFTWARE & INFORMATICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 272

LATIN AMERICA: HTS SOFTWARE & INFORMATICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 273

MIDDLE EAST: HTS SOFTWARE & INFORMATICS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 274

GCC COUNTRIES: HTS SOFTWARE & INFORMATICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 275

HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)

TABLE 276

CELL-BASED SCREENING TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 277

NORTH AMERICA: CELL-BASED SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 278

EUROPE: CELL-BASED SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 279

ASIA PACIFIC: CELL-BASED SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 280

LATIN AMERICA: CELL-BASED SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 281

MIDDLE EAST: CELL-BASED SCREENING TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 282

GCC COUNTRIES: CELL-BASED SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 283

ULTRA-HIGH-THROUGHPUT & AUTOMATION TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 284

NORTH AMERICA: ULTRA-HIGH-THROUGHPUT & AUTOMATION TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 285

EUROPE: ULTRA-HIGH-THROUGHPUT & AUTOMATION TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 286

ASIA PACIFIC: ULTRA-HIGH-THROUGHPUT & AUTOMATION TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 287

LATIN AMERICA: ULTRA-HIGH-THROUGHPUT & AUTOMATION TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 288

MIDDLE EAST: ULTRA-HIGH-THROUGHPUT & AUTOMATION TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 289

GCC COUNTRIES: ULTRA-HIGH-THROUGHPUT & AUTOMATION TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 290

HIGH-CONTENT SCREENING (HCS) TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 291

NORTH AMERICA: HIGH-CONTENT SCREENING (HCS) TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 292

EUROPE: HIGH-CONTENT SCREENING (HCS) TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 293

ASIA PACIFIC: HIGH-CONTENT SCREENING (HCS) TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 294

LATIN AMERICA: HIGH-CONTENT SCREENING (HCS) TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 295

MIDDLE EAST: HIGH-CONTENT SCREENING (HCS) TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 296

GCC COUNTRIES: HIGH-CONTENT SCREENING (HCS) TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 297

BIOCHEMICAL SCREENING TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 298

NORTH AMERICA: BIOCHEMICAL SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 299

EUROPE: BIOCHEMICAL SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 300

ASIA PACIFIC: BIOCHEMICAL SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 301

LATIN AMERICA: BIOCHEMICAL SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 302

MIDDLE EAST: BIOCHEMICAL SCREENING TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 303

GCC COUNTRIES: BIOCHEMICAL SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 304

3D CELL CULTURE & ADVANCED CELLULAR MODEL TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 305

NORTH AMERICA: 3D CELL CULTURE & ADVANCED CELLULAR MODEL TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 306

EUROPE: 3D CELL CULTURE & ADVANCED CELLULAR MODEL TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 307

ASIA PACIFIC: 3D CELL CULTURE & ADVANCED CELLULAR MODEL TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 308

LATIN AMERICA: 3D CELL CULTURE & ADVANCED CELLULAR MODEL TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 309

MIDDLE EAST: 3D CELL CULTURE & ADVANCED CELLULAR MODEL TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 310

GCC COUNTRIES: 3D CELL CULTURE & ADVANCED CELLULAR MODEL TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 311

LABEL-FREE SCREENING TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 312

NORTH AMERICA: LABEL-FREE SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 313

EUROPE: LABEL-FREE SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 314

ASIA PACIFIC: LABEL-FREE SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 315

LATIN AMERICA: LABEL-FREE SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 316

MIDDLE EAST: LABEL-FREE SCREENING TECHNOLOGIES MARKE T, BY REGION, 2024–2031 (USD MILLION)

TABLE 317

GCC COUNTRIES: LABEL-FREE SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 318

OTHER HTS TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 319

NORTH AMERICA: OTHER HTS TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 320

EUROPE: OTHER HTS TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 321

ASIA PACIFIC: OTHER HTS TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 322

LATIN AMERICA: OTHER HTS TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 323

MIDDLE EAST: OTHER HTS TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 324

GCC COUNTRIES: OTHER HTS TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 325

HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)

TABLE 326

HTS PRODUCTS MARKET FOR PRIMARY SCREENING, BY REGION, 2024–2031 (USD MILLION)

TABLE 327

NORTH AMERICA: HTS PRODUCTS MARKET FOR PRIMARY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 328

EUROPE: HTS PRODUCTS MARKET FOR PRIMARY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 329

ASIA PACIFIC: HTS PRODUCTS MARKET FOR PRIMARY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 330

LATIN AMERICA: HTS PRODUCTS MARKET FOR PRIMARY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 331

MIDDLE EAST: HTS PRODUCTS MARKET FOR PRIMARY SCREENING, BY REGION, 2024–2031 (USD MILLION)

TABLE 332

GCC COUNTRIES: HTS PRODUCTS MARKET FOR PRIMARY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 333

HTS PRODUCTS MARKET FOR ASSAY DEVELOPMENT & OPTIMIZATION, BY REGION, 2024–2031 (USD MILLION)

TABLE 334

NORTH AMERICA: HTS PRODUCTS MARKET FOR ASSAY DEVELOPMENT & OPTIMIZATION, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 335

EUROPE: HTS PRODUCTS MARKET FOR ASSAY DEVELOPMENT & OPTIMIZATION, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 336

ASIA PACIFIC: HTS PRODUCTS MARKET FOR ASSAY DEVELOPMENT & OPTIMIZATION, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 337

LATIN AMERICA: HTS PRODUCTS MARKET FOR ASSAY DEVELOPMENT & OPTIMIZATION, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 338

MIDDLE EAST: HTS PRODUCTS MARKET FOR ASSAY DEVELOPMENT & OPTIMIZATION, BY REGION, 2024–2031 (USD MILLION)

TABLE 339

GCC COUNTRIES: HTS PRODUCTS MARKET FOR ASSAY DEVELOPMENT & OPTIMIZATION, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 340

HTS PRODUCTS MARKET FOR HIT CONFIRMATION/SECONDARY SCREENING, BY REGION, 2024–2031 (USD MILLION)

TABLE 341

NORTH AMERICA: HTS PRODUCTS MARKET FOR HIT CONFIRMATION/SECONDARY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 342

EUROPE: HTS PRODUCTS MARKET FOR HIT CONFIRMATION/SECONDARY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 343

ASIA PACIFIC: HTS PRODUCTS MARKET FOR HIT CONFIRMATION/SECONDARY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 344

LATIN AMERICA: HTS PRODUCTS MARKET FOR HIT CONFIRMATION/SECONDARY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 345

MIDDLE EAST: HTS PRODUCTS MARKET FOR HIT CONFIRMATION/SECONDARY SCREENING, BY REGION, 2024–2031 (USD MILLION)

TABLE 346

GCC COUNTRIES: HTS PRODUCTS MARKET FOR HIT CONFIRMATION/SECONDARY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 347

HTS PRODUCTS MARKET FOR DATA ANALYSIS & HIT IDENTIFICATION, BY REGION, 2024–2031 (USD MILLION)

TABLE 348

NORTH AMERICA: HTS PRODUCTS MARKET FOR DATA ANALYSIS & HIT IDENTIFICATION, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 349

EUROPE: HTS PRODUCTS MARKET FOR DATA ANALYSIS & HIT IDENTIFICATION, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 350

ASIA PACIFIC: HTS PRODUCTS MARKET FOR DATA ANALYSIS & HIT IDENTIFICATION, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 351

LATIN AMERICA: HTS PRODUCTS MARKET FOR DATA ANALYSIS & HIT IDENTIFICATION, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 352

MIDDLE EAST: HTS PRODUCTS MARKET FOR DATA ANALYSIS & HIT IDENTIFICATION, BY REGION, 2024–2031 (USD MILLION)

TABLE 353

GCC COUNTRIES: HTS PRODUCTS MARKET FOR DATA ANALYSIS & HIT IDENTIFICATION, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 354

HTS PRODUCTS MARKET FOR COMPOUND LIBRARY PREPARATION, BY REGION, 2024–2031 (USD MILLION)

TABLE 355

NORTH AMERICA: HTS PRODUCTS MARKET FOR COMPOUND LIBRARY PREPARATION, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 356

EUROPE: HTS PRODUCTS MARKET FOR COMPOUND LIBRARY PREPARATION, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 357

ASIA PACIFIC: HTS PRODUCTS MARKET FOR COMPOUND LIBRARY PREPARATION, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 358

LATIN AMERICA: HTS PRODUCTS MARKET FOR COMPOUND LIBRARY PREPARATION, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 359

MIDDLE EAST: HTS PRODUCTS MARKET FOR COMPOUND LIBRARY PREPARATION, BY REGION, 2024–2031 (USD MILLION)

TABLE 360

GCC COUNTRIES: HTS PRODUCTS MARKET FOR COMPOUND LIBRARY PREPARATION, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 361

HTS PRODUCTS MARKET FOR HIT VALIDATION & CHARACTERIZATION, BY REGION, 2024–2031 (USD MILLION)

TABLE 362

NORTH AMERICA: HTS PRODUCTS MARKET FOR HIT VALIDATION & CHARACTERIZATION, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 363

EUROPE: HTS PRODUCTS MARKET FOR HIT VALIDATION & CHARACTERIZATION, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 364

ASIA PACIFIC: HTS PRODUCTS MARKET FOR HIT VALIDATION & CHARACTERIZATION, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 365

LATIN AMERICA: HTS PRODUCTS MARKET FOR HIT VALIDATION & CHARACTERIZATION, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 366

MIDDLE EAST: HTS PRODUCTS MARKET FOR HIT VALIDATION & CHARACTERIZATION, BY REGION, 2024–2031 (USD MILLION)

TABLE 367

GCC COUNTRIES: HTS PRODUCTS MARKET FOR HIT VALIDATION & CHARACTERIZATION, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 368

HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 369

HTS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)

TABLE 370

NORTH AMERICA: HTS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 371

EUROPE: HTS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 372

ASIA PACIFIC: HTS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 373

LATIN AMERICA: HTS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 374

MIDDLE EAST: HTS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)

TABLE 375

GCC COUNTRIES: HTS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 376

HTS PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2024–2031 (USD MILLION)

TABLE 377

NORTH AMERICA: HTS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 378

EUROPE: HTS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 379

ASIA PACIFIC: HTS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 380

LATIN AMERICA: HTS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 381

MIDDLE EAST: HTS PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2024–2031 (USD MILLION)

TABLE 382

GCC COUNTRIES: HTS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 383

HTS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION)

TABLE 384

NORTH AMERICA: HTS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 385

EUROPE: HTS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 386

ASIA PACIFIC: HTS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 387

LATIN AMERICA: HTS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 388

MIDDLE EAST: HTS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION)

TABLE 389

GCC COUNTRIES: HTS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 390

HTS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)

TABLE 391

NORTH AMERICA: HTS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 392

EUROPE: HTS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 393

ASIA PACIFIC: HTS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 394

LATIN AMERICA: HTS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 395

MIDDLE EAST: HTS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)

TABLE 396

GCC COUNTRIES: HTS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 397

HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 398

PRIMARY SCREENING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 399

NORTH AMERICA: PRIMARY SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 400

EUROPE: PRIMARY SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 401

ASIA PACIFIC: PRIMARY SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 402

LATIN AMERICA: PRIMARY SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 403

MIDDLE EAST: PRIMARY SCREENING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 404

GCC COUNTRIES: PRIMARY SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 405

ASSAY DEVELOPMENT & OPTIMIZATION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 406

NORTH AMERICA: ASSAY DEVELOPMENT & OPTIMIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 407

EUROPE: ASSAY DEVELOPMENT & OPTIMIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 408

ASIA PACIFIC: ASSAY DEVELOPMENT & OPTIMIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 409

LATIN AMERICA: ASSAY DEVELOPMENT & OPTIMIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 410

MIDDLE EAST: ASSAY DEVELOPMENT & OPTIMIZATION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 411

GCC COUNTRIES: ASSAY DEVELOPMENT & OPTIMIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 412

SECONDARY SCREENING & HIT CONFIRMATION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 413

NORTH AMERICA: SECONDARY SCREENING & HIT CONFIRMATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 414

EUROPE: SECONDARY SCREENING & HIT CONFIRMATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 415

ASIA PACIFIC: SECONDARY SCREENING & HIT CONFIRMATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 416

LATIN AMERICA: SECONDARY SCREENING & HIT CONFIRMATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 417

MIDDLE EAST: SECONDARY SCREENING & HIT CONFIRMATION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 418

GCC COUNTRIES: SECONDARY SCREENING & HIT CONFIRMATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 419

HIT VALIDATION & CHARACTERIZATION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 420

NORTH AMERICA: HIT VALIDATION & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 421

EUROPE: HIT VALIDATION & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 422

ASIA PACIFIC: HIT VALIDATION & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 423

LATIN AMERICA: HIT VALIDATION & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 424

MIDDLE EAST: HIT VALIDATION & CHARACTERIZATION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 425

GCC COUNTRIES: HIT VALIDATION & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 426

COMPOUND LIBRARY MANAGEMENT SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 427

NORTH AMERICA: COMPOUND LIBRARY MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 428

EUROPE: COMPOUND LIBRARY MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 429

ASIA PACIFIC: COMPOUND LIBRARY MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 430

LATIN AMERICA: COMPOUND LIBRARY MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 431

MIDDLE EAST: COMPOUND LIBRARY MANAGEMENT SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 432

GCC COUNTRIES: COMPOUND LIBRARY MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 433

DATA ANALYSIS & INFORMATICS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 434

NORTH AMERICA: DATA ANALYSIS & INFORMATICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 435

EUROPE: DATA ANALYSIS & INFORMATICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 436

ASIA PACIFIC: DATA ANALYSIS & INFORMATICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 437

LATIN AMERICA: DATA ANALYSIS & INFORMATICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 438

MIDDLE EAST: DATA ANALYSIS & INFORMATICS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 439

GCC COUNTRIES: DATA ANALYSIS & INFORMATICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 440

OTHER HTS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 441

NORTH AMERICA: OTHER HTS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 442

EUROPE: OTHER HTS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 443

ASIA PACIFIC: OTHER HTS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 444

LATIN AMERICA: OTHER HTS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 445

MIDDLE EAST: OTHER HTS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 446

GCC COUNTRIES: OTHER HTS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 447

HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 448

HTS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)

TABLE 449

NORTH AMERICA: HTS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 450

EUROPE: HTS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 451

ASIA PACIFIC: HTS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 452

LATIN AMERICA: HTS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 453

MIDDLE EAST: HTS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)

TABLE 454

GCC COUNTRIES: HTS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 455

HTS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION)

TABLE 456

NORTH AMERICA: HTS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 457

EUROPE: HTS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 458

ASIA PACIFIC: HTS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 459

LATIN AMERICA: HTS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 460

MIDDLE EAST: HTS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION)

TABLE 461

GCC COUNTRIES: HTS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 462

HTS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)

TABLE 463

NORTH AMERICA: HTS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 464

EUROPE: HTS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 465

ASIA PACIFIC: HTS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 466

LATIN AMERICA: HTS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 467

MIDDLE EAST: HTS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)

TABLE 468

GCC COUNTRIES: HTS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 469

HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 470

HTS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024–2031 (USD MILLION)

TABLE 471

NORTH AMERICA: HTS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 472

EUROPE: HTS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 473

ASIA PACIFIC: HTS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 474

LATIN AMERICA: HTS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 475

MIDDLE EAST: HTS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024–2031 (USD MILLION)

TABLE 476

GCC COUNTRIES: HTS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 477

HTS MARKET FOR BASIC RESEARCH & FUNCTIONAL GENOMICS, BY REGION, 2024–2031 (USD MILLION)

TABLE 478

NORTH AMERICA: HTS MARKET FOR BASIC RESEARCH & FUNCTIONAL GENOMICS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 479

EUROPE: HTS MARKET FOR BASIC RESEARCH & FUNCTIONAL GENOMICS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 480

ASIA PACIFIC: HTS MARKET FOR BASIC RESEARCH & FUNCTIONAL GENOMICS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 481

LATIN AMERICA: HTS MARKET FOR BASIC RESEARCH & FUNCTIONAL GENOMICS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 482

MIDDLE EAST: HTS MARKET FOR BASIC RESEARCH & FUNCTIONAL GENOMICS, BY REGION, 2024–2031 (USD MILLION)

TABLE 483

GCC COUNTRIES: HTS MARKET FOR BASIC RESEARCH & FUNCTIONAL GENOMICS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 484

HTS MARKET FOR TOXICOLOGY & SAFETY SCREENING, BY REGION, 2024–2031 (USD MILLION)

TABLE 485

NORTH AMERICA: HTS MARKET FOR TOXICOLOGY & SAFETY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 486

EUROPE: HTS MARKET FOR TOXICOLOGY & SAFETY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 487

ASIA PACIFIC: HTS MARKET FOR TOXICOLOGY & SAFETY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 488

LATIN AMERICA: HTS MARKET FOR TOXICOLOGY & SAFETY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 489

MIDDLE EAST: HTS MARKET FOR TOXICOLOGY & SAFETY SCREENING, BY REGION, 2024–2031 (USD MILLION)

TABLE 490

GCC COUNTRIES: HTS MARKET FOR TOXICOLOGY & SAFETY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 491

HTS MARKET FOR PRECISION MEDICINE & BIOMARKER DISCOVERY, BY REGION, 2024–2031 (USD MILLION)

TABLE 492

NORTH AMERICA: HTS MARKET FOR PRECISION MEDICINE & BIOMARKER DISCOVERY, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 493

EUROPE: HTS MARKET FOR PRECISION MEDICINE & BIOMARKER DISCOVERY, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 494

ASIA PACIFIC: HTS MARKET FOR PRECISION MEDICINE & BIOMARKER DISCOVERY, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 495

LATIN AMERICA: HTS MARKET FOR PRECISION MEDICINE & BIOMARKER DISCOVERY, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 496

MIDDLE EAST: HTS MARKET FOR PRECISION MEDICINE & BIOMARKER DISCOVERY, BY REGION, 2024–2031 (USD MILLION)

TABLE 497

GCC COUNTRIES: HTS MARKET FOR PRECISION MEDICINE & BIOMARKER DISCOVERY, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 498

HTS MARKET FOR STEM CELL & REGENERATIVE MEDICINE RESEARCH, BY REGION, 2024–2031 (USD MILLION)

TABLE 499

NORTH AMERICA: HTS MARKET FOR STEM CELL & REGENERATIVE MEDICINE RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 500

EUROPE: HTS MARKET FOR STEM CELL & REGENERATIVE MEDICINE RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 501

ASIA PACIFIC: HTS MARKET FOR STEM CELL & REGENERATIVE MEDICINE RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 502

LATIN AMERICA: HTS MARKET FOR STEM CELL & REGENERATIVE MEDICINE RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 503

MIDDLE EAST: HTS MARKET FOR STEM CELL & REGENERATIVE MEDICINE RESEARCH, BY REGION, 2024–2031 (USD MILLION)

TABLE 504

GCC COUNTRIES: HTS MARKET FOR STEM CELL & REGENERATIVE MEDICINE RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 505

HTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)

TABLE 506

NORTH AMERICA: HTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 507

EUROPE: HTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 508

ASIA PACIFIC: HTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 509

LATIN AMERICA: HTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 510

MIDDLE EAST: HTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)

TABLE 511

GCC COUNTRIES: HTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 512

HIGH-THROUGHPUT SCREENING MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 513

HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 514

HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 515

NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 516

NORTH AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 517

NORTH AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 518

NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)

TABLE 519

NORTH AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 520

NORTH AMERICA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 521

NORTH AMERICA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 522

NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 523

NORTH AMERICA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 524

NORTH AMERICA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 525

NORTH AMERICA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 526

NORTH AMERICA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 527

NORTH AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)

TABLE 528

NORTH AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)

TABLE 529

NORTH AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 530

NORTH AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 531

NORTH AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 532

NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 533

US: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)

TABLE 534

US: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 535

US: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 536

US: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 537

US: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 538

US: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 539

US: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 540

US: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 541

US: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 542

US: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)

TABLE 543

US: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)

TABLE 544

US: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 545

US: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 546

US: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 547

US: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 548

CANADA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)

TABLE 549

CANADA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 550

CANADA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 551

CANADA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 552

CANADA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 553

CANADA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 554

CANADA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 555

CANADA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 556

CANADA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 557

CANADA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)

TABLE 558

CANADA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)

TABLE 559

CANADA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 560

CANADA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 561

CANADA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 562

CANADA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 563

EUROPE: HIGH-THROUGHPUT SCREENING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 564

EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 565

EUROPE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 566

EUROPE: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)

TABLE 567

EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 568

EUROPE: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 569

EUROPE: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 570

EUROPE: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 571

EUROPE: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 572

EUROPE: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 573

EUROPE: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 574

EUROPE: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 575

EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)

TABLE 576

EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)

TABLE 577

EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 578

EUROPE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 579

EUROPE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 580

EUROPE: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 581

GERMANY: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)

TABLE 582

GERMANY: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 583

GERMANY: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 584

GERMANY: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 585

GERMANY: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 586

GERMANY: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 587

GERMANY: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 588

GERMANY: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 589

GERMANY: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 590

GERMANY: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)

TABLE 591

GERMANY: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)

TABLE 592

GERMANY: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 593

GERMANY: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 594

GERMANY: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 595

GERMANY: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 596

UK: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)

TABLE 597

UK: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 598

UK: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 599

UK: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 600

UK: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 601

UK: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 602

UK: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 603

UK: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 604

UK: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 605

UK: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)

TABLE 606

UK: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)

TABLE 607

UK: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 608

UK: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 609

UK: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 610

UK: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 611

FRANCE: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)

TABLE 612

FRANCE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 613

FRANCE: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 614

FRANCE: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 615

FRANCE: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 616

FRANCE: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 617

FRANCE: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 618

FRANCE: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 619

FRANCE: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 620

FRANCE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)

TABLE 621

FRANCE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)

TABLE 622

FRANCE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 623

FRANCE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 624

FRANCE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 625

FRANCE: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 626

ITALY: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)

TABLE 627

ITALY: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 628

ITALY: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 629

ITALY: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 630

ITALY: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 631

ITALY: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 632

ITALY: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 633

ITALY: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 634

ITALY: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 635

ITALY: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)

TABLE 636

ITALY: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)

TABLE 637

ITALY: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 638

ITALY: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 639

ITALY: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 640

ITALY: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 641

SPAIN: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)

TABLE 642

SPAIN: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 643

SPAIN: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 644

SPAIN: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 645

SPAIN: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 646

SPAIN: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 647

SPAIN: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 648

SPAIN: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 649

SPAIN: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 650

SPAIN: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)

TABLE 651

SPAIN: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)

TABLE 652

SPAIN: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 653

SPAIN: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 654

SPAIN: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 655

SPAIN: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 656

REST OF EUROPE: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)

TABLE 657

REST OF EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 658

REST OF EUROPE: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 659

REST OF EUROPE: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 660

REST OF EUROPE: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 661

REST OF EUROPE: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 662

REST OF EUROPE: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 663

REST OF EUROPE: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 664

REST OF EUROPE: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 665

REST OF EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)

TABLE 666

REST OF EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)

TABLE 667

REST OF EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 668

REST OF EUROPE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 669

REST OF EUROPE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 670

REST OF EUROPE: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 671

ASIA PACIFIC: HIGH-THROUGHPUT SCREENING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 672

ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 673

ASIA PACIFIC: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 674

ASIA PACIFIC: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)

TABLE 675

ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 676

ASIA PACIFIC: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 677

ASIA PACIFIC: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 678

ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 679

ASIA PACIFIC: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 680

ASIA PACIFIC: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 681

ASIA PACIFIC: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 682

ASIA PACIFIC: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 683

ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)

TABLE 684

ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)

TABLE 685

ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 686

ASIA PACIFIC: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 687

ASIA PACIFIC: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 688

ASIA PACIFIC: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 689

CHINA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)

TABLE 690

CHINA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 691

CHINA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 692

CHINA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 693

CHINA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 694

CHINA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 695

CHINA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 696

CHINA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 697

CHINA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 698

CHINA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)

TABLE 699

CHINA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)

TABLE 700

CHINA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 701

CHINA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 702

CHINA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 703

CHINA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 704

JAPAN: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)

TABLE 705

JAPAN: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 706

JAPAN: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 707

JAPAN: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 708

JAPAN: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 709

JAPAN: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 710

JAPAN: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 711

JAPAN: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 712

JAPAN: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 713

JAPAN: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)

TABLE 714

JAPAN: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)

TABLE 715

JAPAN: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 716

JAPAN: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 717

JAPAN: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 718

JAPAN: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 719

INDIA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)

TABLE 720

INDIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 721

INDIA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 722

INDIA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 723

INDIA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 724

INDIA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 725

INDIA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 726

INDIA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 727

INDIA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 728

INDIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)

TABLE 729

INDIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)

TABLE 730

INDIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 731

INDIA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 732

INDIA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 733

INDIA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 734

AUSTRALIA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)

TABLE 735

AUSTRALIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 736

AUSTRALIA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 737

AUSTRALIA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 738

AUSTRALIA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 739

AUSTRALIA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 740

AUSTRALIA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 741

AUSTRALIA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 742

AUSTRALIA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 743

AUSTRALIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)

TABLE 744

AUSTRALIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)

TABLE 745

AUSTRALIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 746

AUSTRALIA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 747

AUSTRALIA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 748

AUSTRALIA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 749

SOUTH KOREA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)

TABLE 750

SOUTH KOREA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 751

SOUTH KOREA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 752

SOUTH KOREA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 753

SOUTH KOREA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 754

SOUTH KOREA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 755

SOUTH KOREA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 756

SOUTH KOREA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 757

SOUTH KOREA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 758

SOUTH KOREA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)

TABLE 759

SOUTH KOREA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)

TABLE 760

SOUTH KOREA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 761

SOUTH KOREA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 762

SOUTH KOREA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 763

SOUTH KOREA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 764

REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)

TABLE 765

REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 766

REST OF ASIA PACIFIC: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 767

REST OF ASIA PACIFIC: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 768

REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 769

REST OF ASIA PACIFIC: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 770

REST OF ASIA PACIFIC: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 771

REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 772

REST OF ASIA PACIFIC: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 773

REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)

TABLE 774

REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)

TABLE 775

REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 776

REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 777

REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 778

REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 779

LATIN AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 780

LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 781

LATIN AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 782

LATIN AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)

TABLE 783

LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 784

LATIN AMERICA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 785

LATIN AMERICA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 786

LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 787

LATIN AMERICA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 788

LATIN AMERICA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 789

LATIN AMERICA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 790

LATIN AMERICA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 791

LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)

TABLE 792

LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)

TABLE 793

LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 794

LATIN AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 795

LATIN AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 796

LATIN AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 797

BRAZIL: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)

TABLE 798

BRAZIL: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 799

BRAZIL: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 800

BRAZIL: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 801

BRAZIL: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 802

BRAZIL: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 803

BRAZIL: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 804

BRAZIL: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 805

BRAZIL: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 806

BRAZIL: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)

TABLE 807

BRAZIL: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)

TABLE 808

BRAZIL: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 809

BRAZIL: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 810

BRAZIL: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 811

BRAZIL: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 812

MEXICO: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)

TABLE 813

MEXICO: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 814

MEXICO: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 815

MEXICO: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 816

MEXICO: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 817

MEXICO: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 818

MEXICO: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 819

MEXICO: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 820

MEXICO: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 821

MEXICO: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)

TABLE 822

MEXICO: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)

TABLE 823

MEXICO: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 824

MEXICO: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 825

MEXICO: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 826

MEXICO: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 827

REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)

TABLE 828

REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 829

REST OF LATIN AMERICA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 830

REST OF LATIN AMERICA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 831

REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 832

REST OF LATIN AMERICA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 833

REST OF LATIN AMERICA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 834

REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 835

REST OF LATIN AMERICA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 836

REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)

TABLE 837

REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)

TABLE 838

REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 839

REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 840

REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 841

REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 842

MIDDLE EAST: HIGH-THROUGHPUT SCREENING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 843

MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 844

MIDDLE EAST: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 845

MIDDLE EAST: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)

TABLE 846

MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 847

MIDDLE EAST: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 848

MIDDLE EAST: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 849

MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 850

MIDDLE EAST: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 851

MIDDLE EAST: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 852

MIDDLE EAST: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 853

MIDDLE EAST: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 854

MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)

TABLE 855

MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)

TABLE 856

MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 857

MIDDLE EAST: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 858

MIDDLE EAST: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 859

MIDDLE EAST: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 860

GCC COUNTRIES: HIGH-THROUGHPUT SCREENING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 861

GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 862

GCC COUNTRIES: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 863

GCC COUNTRIES: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)

TABLE 864

GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 865

GCC COUNTRIES: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 866

GCC COUNTRIES: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 867

GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 868

GCC COUNTRIES: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 869

GCC COUNTRIES: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 870

GCC COUNTRIES: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 871

GCC COUNTRIES: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 872

GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)

TABLE 873

GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)

TABLE 874

GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 875

GCC COUNTRIES: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 876

GCC COUNTRIES: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 877

GCC COUNTRIES: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 878

SAUDI ARABIA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)

TABLE 879

SAUDI ARABIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 880

SAUDI ARABIA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 881

SAUDI ARABIA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 882

SAUDI ARABIA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 883

SAUDI ARABIA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 884

SAUDI ARABIA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 885

SAUDI ARABIA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 886

SAUDI ARABIA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 887

SAUDI ARABIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)

TABLE 888

SAUDI ARABIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)

TABLE 889

SAUDI ARABIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 890

SAUDI ARABIA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 891

SAUDI ARABIA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 892

SAUDI ARABIA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 893

UAE: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)

TABLE 894

UAE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 895

UAE: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 896

UAE: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 897

UAE: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 898

UAE: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 899

UAE: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 900

UAE: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 901

UAE: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 902

UAE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)

TABLE 903

UAE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)

TABLE 904

UAE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 905

UAE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 906

UAE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 907

UAE: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 908

REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)

TABLE 909

REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 910

REST OF GCC COUNTRIES: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 911

REST OF GCC COUNTRIES: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 912

REST OF GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 913

REST OF GCC COUNTRIES: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 914

REST OF GCC COUNTRIES: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 915

REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 916

REST OF GCC COUNTRIES: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 917

REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)

TABLE 918

REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)

TABLE 919

REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 920

REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 921

REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 922

REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 923

REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)

TABLE 924

REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 925

REST OF MIDDLE EAST: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 926

REST OF MIDDLE EAST: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 927

REST OF MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 928

REST OF MIDDLE EAST: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 929

REST OF MIDDLE EAST: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 930

REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 931

REST OF MIDDLE EAST: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 932

REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)

TABLE 933

REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)

TABLE 934

REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 935

REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 936

REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 937

REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 938

AFRICA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)

TABLE 939

AFRICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 940

AFRICA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 941

AFRICA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 942

AFRICA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 943

AFRICA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 944

AFRICA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 945

AFRICA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 946

AFRICA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 947

AFRICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)

TABLE 948

AFRICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)

TABLE 949

AFRICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 950

AFRICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 951

AFRICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 952

AFRICA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 953

OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN HIGH-THROUGHPUT SCREENING MARKET

TABLE 954

HIGH-THROUGHPUT SCREENING MARKET: DEGREE OF COMPETITION

TABLE 955

HIGH-THROUGHPUT SCREENING MARKET: REGION FOOTPRINT

TABLE 956

HIGH-THROUGHPUT SCREENING MARKET: OFFERING FOOTPRINT

TABLE 957

HIGH-THROUGHPUT SCREENING MARKET: PRODUCT TYPE FOOTPRINT

TABLE 958

HIGH-THROUGHPUT SCREENING MARKET: APPLICATION FOOTPRINT

TABLE 959

HIGH-THROUGHPUT SCREENING MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS

TABLE 960

HIGH-THROUGHPUT SCREENING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY OFFERING AND REGION

TABLE 961

HIGH-THROUGHPUT SCREENING MARKET: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026

TABLE 962

HIGH-THROUGHPUT SCREENING MARKET: DEALS, JANUARY 2023–APRIL 2026

TABLE 963

HIGH-THROUGHPUT SCREENING MARKET: EXPANSIONS, JANUARY 2023–APRIL 2026

TABLE 964

THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW

TABLE 965

THERMO FISHER SCIENTIFIC INC.: PRODUCTS & SERVICES OFFERED

TABLE 966

THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026

TABLE 967

THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2023–APRIL 2026

TABLE 968

THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2023–APRIL 2026

TABLE 969

DANAHER CORPORATION: COMPANY OVERVIEW

TABLE 970

DANAHER CORPORATION: PRODUCTS & SERVICES OFFERED

TABLE 971

DANAHER CORPORATION: PRODUCT & SERVICE LAUNCHES, JANUARY 2023–APRIL 2026

TABLE 972

DANAHER CORPORATION: DEALS, JANUARY 2023–APRIL 2026

TABLE 973

MERCK KGAA: COMPANY OVERVIEW

TABLE 974

MERCK KGAA: PRODUCTS & SERVICES OFFERED

TABLE 975

MERCK KGAA: DEALS, JANUARY 2023–APRIL 2026

TABLE 976

MERCK KGAA: EXPANSIONS, JANUARY 2023–APRIL 2026

TABLE 977

MERCK KGAA: OTHER DEVELOPMENTS, JANUARY 2023–APRIL 2026

TABLE 978

AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW

TABLE 979

AGILENT TECHNOLOGIES, INC.: PRODUCTS & SERVICES OFFERED

TABLE 980

AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023–APRIL 2026

TABLE 981

AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2023–APRIL 2026

TABLE 982

AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2023–APRIL 2026

TABLE 983

AGILENT TECHNOLOGIES, INC.: OTHER DEVELOPMENTS, JANUARY 2023–APRIL 2026

TABLE 984

REVVITY, INC.: COMPANY OVERVIEW

TABLE 985

REVVITY INC.: PRODUCTS & SERVICES OFFERED

TABLE 986

REVVITY, INC.: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026

TABLE 987

REVVITY, INC.: DEALS, JANUARY 2023–APRIL 2026

TABLE 988

TECAN GROUP LTD.: COMPANY OVERVIEW

TABLE 989

TECAN GROUP LTD.: PRODUCTS & SERVICES OFFERED

TABLE 990

TECAN GROUP LTD.: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026

TABLE 991

TECAN GROUP LTD.: DEALS, JANUARY 2023–APRIL 2026

TABLE 992

BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW

TABLE 993

BIO-RAD LABORATORIES, INC.: PRODUCTS & SERVICES OFFERED

TABLE 994

BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026

TABLE 995

CORNING INCORPORATED: COMPANY OVERVIEW

TABLE 996

CORNING INCORPORATED: PRODUCTS & SERVICES OFFERED

TABLE 997

METTLER-TOLEDO INTERNATIONAL INC.: COMPANY OVERVIEW

TABLE 998

METTLER-TOLEDO INTERNATIONAL INC.: PRODUCTS & SERVICES OFFERED

TABLE 999

LONZA GROUP: COMPANY OVERVIEW

TABLE 1000

LONZA GROUP: PRODUCTS & SERVICES OFFERED

TABLE 1001

WATERS CORPORATION: COMPANY OVERVIEW

TABLE 1002

WATERS CORPORATION: PRODUCTS & SERVICES OFFERED

TABLE 1003

WATERS CORPORATION: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026

TABLE 1004

WATERS CORPORATION: DEALS, JANUARY 2023–APRIL 2026

TABLE 1005

SARTORIUS AG: COMPANY OVERVIEW

TABLE 1006

SARTORIUS AG: PRODUCTS & SERVICES OFFERED

TABLE 1007

SARTORIUS AG: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026

TABLE 1008

SARTORIUS AG: DEALS, JANUARY 2023–APRIL 2026

TABLE 1009

SARTORIUS AG: EXPANSIONS, JANUARY 2023–APRIL 2026

TABLE 1010

EPPENDORF SE: COMPANY OVERVIEW

TABLE 1011

EPPENDORF SE: PRODUCTS & SERVICES OFFERED

TABLE 1012

EPPENDORF SE: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026

TABLE 1013

EPPENDORF SE: DEALS, JANUARY 2023–APRIL 2026

TABLE 1014

EPPENDORF SE: EXPANSIONS, JANUARY 2023–APRIL 2026

TABLE 1015

PORVAIR PLC: COMPANY OVERVIEW

TABLE 1016

PORVAIR PLC: PRODUCTS & SERVICES OFFERED

TABLE 1017

GREINER AG: COMPANY OVERVIEW

TABLE 1018

GREINER AG: PRODUCTS & SERVICES OFFERED

TABLE 1019

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY OVERVIEW

TABLE 1020

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: PRODUCTS & SERVICES OFFERED

TABLE 1021

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: DEALS, JANUARY 2023–APRIL 2026

TABLE 1022

EUROFINS SCIENTIFIC: COMPANY OVERVIEW

TABLE 1023

EUROFINS SCIENTIFIC: PRODUCTS & SERVICES OFFERED

TABLE 1024

EUROFINS SCIENTIFIC: SERVICE LAUNCHES

TABLE 1025

EUROFINS SCIENTIFIC: DEALS, JANUARY 2023–APRIL 2026

TABLE 1026

EUROFINS SCIENTIFIC: EXPANSIONS, JANUARY 2023–APRIL 2026

TABLE 1027

HAMILTON COMPANY: COMPANY OVERVIEW

TABLE 1028

HAMILTON COMPANY: PRODUCTS & SERVICES OFFERED

TABLE 1029

HAMILTON COMPANY: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026

TABLE 1030

HAMILTON COMPANY: DEALS, JANUARY 2023–APRIL 2026

TABLE 1031

AURORA BIOMED INC.: COMPANY OVERVIEW

TABLE 1032

AURORA BIOMED INC.: PRODUCTS & SERVICES OFFERED

TABLE 1033

GILSON INCORPORATED: COMPANY OVERVIEW

TABLE 1034

GILSON INCORPORATED: PRODUCTS & SERVICES OFFERED

TABLE 1035

BRAND GMBH + CO KG: COMPANY OVERVIEW

TABLE 1036

BRAND GMBH + CO KG: PRODUCTS & SERVICES OFFERED

TABLE 1037

IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS

TABLE 1038

RISK ASSESSMENT

FIGURE 1

HTS MARKET SEGMENTATION

FIGURE 2

REGIONS CONSIDERED

FIGURE 3

HIGH-THROUGHPUT SCREENING MARKET: YEARS CONSIDERED

FIGURE 5

GLOBAL HIGH-THROUGHPUT SCREENING MARKET, 2024–2031

FIGURE 6

MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN HIGH-THROUGHPUT SCREENING MARKET, 2023–2026

FIGURE 7

DISRUPTIONS INFLUENCING GROWTH OF HIGH-THROUGHPUT SCREENING MARKET

FIGURE 8

HIGH-GROWTH SEGMENTS IN HIGH-THROUGHPUT SCREENING MARKET, 2026–2031

FIGURE 9

ASIA PACIFIC TO REGISTER HIGHEST CAGR IN HIGH-THROUGHPUT SCREENING MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD

FIGURE 10

GROWING ADOPTION OF OPEN INNOVATIVE MODELS TO DRIVE MARKET GROWTH

FIGURE 11

US AND REAGENTS, KITS, AND CONSUMABLES ACCOUNTED FOR LARGEST SHARE OF HIGH-THROUGHPUT SCREENING MARKET IN NORTH AMERICA IN 2025

FIGURE 12

ASIA PACIFIC LIKELY TO BE FASTEST-GROWING MARKET IN GLOBAL HIGH-THROUGHPUT SCREENING MARKET DURING FORECAST PERIOD

FIGURE 13

PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD

FIGURE 14

HIGH-THROUGHPUT SCREENING (HTS) MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES

FIGURE 15

HIGH-THROUGHPUT SCREENING (HTS) MARKET: PORTER’S FIVE FORCES ANALYSIS

FIGURE 16

GLOBAL GDP GROWTH (2020–2030)

FIGURE 17

HIGH-THROUGHPUT SCREENING (HTS) MARKET: VALUE CHAIN ANALYSIS

FIGURE 18

HIGH-THROUGHPUT SCREENING (HTS) MARKET ECOSYSTEM

FIGURE 19

AVERAGE SELLING PRICE TREND OF LIQUID HANDLING SYSTEMS, BY KEY PLAYER, 2023–2025 (USD)

FIGURE 20

AVERAGE SELLING PRICE OF PRODUCTS, BY REGION, 2025 (USD)

FIGURE 21

REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS IN HIGH-THROUGHPUT SCREENING (HTS) MARKET

FIGURE 22

TOP APPLICANTS/OWNERS (COMPANIES) FOR HIGH-THROUGHPUT SCREENING PATENTS, 2015–2025

FIGURE 23

IMPACT OF AI/GEN AI ON HIGH-THROUGHPUT SCREENING (HTS) MARKET

FIGURE 24

INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING

FIGURE 25

KEY BUYING CRITERIA, BY END USER

FIGURE 26

FLOW CYTOMETRY INSTRUMENTS (CELL ANALYZERS) MARKET, 2024–2031 (UNITS)

FIGURE 27

NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET SNAPSHOT

FIGURE 28

ASIA PACIFIC: HIGHT-THROUGHPUT SCREENING MARKET SNAPSHOT

FIGURE 29

REVENUE ANALYSIS OF KEY PLAYERS, 2021–2025 (USD MILLION)

FIGURE 30

MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025

FIGURE 31

HIGH-THROUGHPUT SCREENING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025

FIGURE 32

HIGH-THROUGHPUT SCREENING MARKET: COMPANY FOOTPRINT

FIGURE 33

HIGH-THROUGHPUT SCREENING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025

FIGURE 34

EV/EBITDA OF KEY VENDORS

FIGURE 35

YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS

FIGURE 36

HIGH-THROUGHPUT SCREENING MARKET: BRAND/PRODUCT/SERVICE COMPARATIVE ANALYSIS

FIGURE 37

THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025)

FIGURE 38

DANAHER CORPORATION: COMPANY SNAPSHOT (2025)

FIGURE 39

MERCK KGAA: COMPANY SNAPSHOT (2025)

FIGURE 40

AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025)

FIGURE 41

REVVITY, INC.: COMPANY SNAPSHOT (2025)

FIGURE 42

TECAN GROUP LTD.: COMPANY SNAPSHOT (2025)

FIGURE 43

BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025)

FIGURE 44

CORNING INCORPORATED: COMPANY SNAPSHOT (2025)

FIGURE 45

METTLER-TOLEDO INTERNATIONAL INC.: COMPANY SNAPSHOT (2025)

FIGURE 46

LONZA GROUP: COMPANY SNAPSHOT (2025)

FIGURE 47

WATERS CORPORATION: COMPANY SNAPSHOT (2025)

FIGURE 48

SARTORIUS AG: COMPANY SNAPSHOT (2025)

FIGURE 49

EPPENDORF SE: COMPANY SNAPSHOT (2024)

FIGURE 50

PORVAIR PLC: COMPANY SNAPSHOT (2025)

FIGURE 51

GREINER AG: COMPANY SNAPSHOT (2025)

FIGURE 52

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT (2025)

FIGURE 53

EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2025)

FIGURE 54

HIGHT-THROUGHPUT SCREENING MARKET: RESEARCH DESIGN

FIGURE 55

HIGHT-THROUGHPUT SCREENING MARKET: BREAKDOWN OF PRIMARIES

FIGURE 56

GLOBAL HIGH-THROUGHPUT SCREENING MARKET ESTIMATION, 2025

FIGURE 57

HIGH-THROUGHPUT SCREENING MARKET: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH) (2025)

FIGURE 58

ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC: REVENUE ANALYSIS (2025)

FIGURE 59

HIGH-THROUGHPUT SCREENING MARKET: INSIGHTS FROM PRIMARIES

FIGURE 60

SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH

FIGURE 61

HIGH-THROUGHPUT SCREENING MARKET: CAGR PROJECTIONS

FIGURE 62

HTS MARKET: DATA TRIANGULATION

Methodology

This research study relied heavily on secondary sources, directories, and databases to identify and collect valuable information for analyzing the global high-throughput screening (HTS) market. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of leading market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with primary research inputs to arrive at the final market size.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive technical, market-oriented, and commercial study of the high-throughput screening (HTS) market. The secondary sources used for this study include World Health Organization (WHO), American Society for Clinical Laboratory Science (ASCLS), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), National Center for Biotechnology Information (NCBI), American Association for Clinical Chemistry (AACC), National Center for Advancing Translational Sciences (NCATS), American Society for Pharmacology and Experimental Therapeutics (ASPET), National Health Service (NHS), Pharmaceuticals and Medical Devices Agency (PMDA), European Medicines Agency (EMA), Society for Laboratory Automation and Screening (SLAS), European Bioinformatics Institute, and Center for Translational Research, among others. Corporate filings include annual reports, SEC filings, investor presentations, and financial statements; research journals; press releases; and trade, business, and professional associations. Secondary data were collected and analyzed to determine the overall size of the global high-throughput screening (HTS) market, which was subsequently validated through primary research. These sources were also used to obtain key information on major players, market classification, and segmentation aligned with industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and to assess the market's future prospects. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

High-Throughput Screening (HTS) Market
Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were employed to estimate and validate the overall size of the high-throughput screening (HTS) market. These methods were also widely used to determine the size of various market segments. The research methodology used to estimate the market size includes the following:

High-Throughput Screening (HTS) Market : Top-Down and Bottom-Up Approach

High-Throughput Screening (HTS) Market Top Down and Bottom Up Approach

Data Triangulation

After estimating the overall market size, the total market was divided into segments and subsegments. Data triangulation and market breakdown techniques were used where applicable to finalize the overall market analysis and obtain precise statistics for all segments and subsegments. The data was triangulated by examining various factors and trends from both demand and supply sides.

Market Definition

High-throughput screening (HTS) is a drug discovery process that involves automated testing of large quantities of chemical or biological compounds against specific biological targets using various binding assays.

The HTS market comprises products (instruments, reagents & consumables, software), and services used to perform automated, parallel screening of large compound or biological libraries against defined biological targets or assays to identify active entities (hits). The high-throughput screening (HTS) market comprises workflow stages from assay development and compound library management to automated large-scale screening and hit identification, culminating in validated screening hits.

Key Stakeholders

Contract research organizations
Pharmaceutical & biopharmaceutical companies
Academic & research institutes
High-throughput screening instrument & reagent manufacturers
High-content screening database, service, and software providers
Venture capitalists & investors
Market research & consulting firms
Government associations
Medical institutions & universities

Report Objectives

To define, describe, and forecast the high-throughput screening (HTS) market by offering, products by type, products by technology, products by workflow, products by end user, services by type, services by end user, application, and region
To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall high-throughput screening (HTS) market
To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
To profile the key players and analyze their market shares and core competencies2
To track and analyze competitive developments, such as product & service launches, agreements, partnerships, acquisitions, and research & development activities
To analyze and provide funding & investment activities, brand/product/service comparative analysis, and vendor valuation & financial metrics of the high-throughput screening (HTS) market

Customization Options

Based on the given market data, MarketsandMarkets offers customization to meet the company’s specific needs. The following customization options are available for this report:

Portfolio Assessment

Product/Service Matrix gives a detailed comparison of the product/service portfolios of the top five companies.

Geographical Analysis

Further breakdown of the Rest of Europe high-throughput screening (HTS) market, by country
Further breakdown of the Rest of Asia Pacific high-throughput screening (HTS) market, by country
Further breakdown of the Rest of Latin America high-throughput screening (HTS) market, by country

JAYANT RAJPUROHIT

Director of Market Insights, Data and Analytics

SFI Health,

Leading Pharmaceutical Company

www.sfihealth.com/

We at SFI Health approached MarketsandMarkets for an Opportunity Assessment on "Incidence and Prevalence of Focus Indications" as we wanted to know the most attractive HCPs like Physician, Functional MD, Naturopath and Pharmacist. The project was critical for us to ensure our focus on the right target which would enable sustainable growth and profitability for SFI Health. The business insights provided exceeded our expectations and we were extremely impressed. The team at MarketsandMarkets is highly professional and detail oriented and very well understood our business needs. MarketsandMarkets offers a unique combination of expertise and dedicated engagement model. We identified 2 new products to be launched in coming months, based on the research findings provided by MarketsandMarkets. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.

BEATRIZ DE LA CALLE

Head of Commercial Analytics

Qualicaps,

Leading Pharmaceutical Company

www.qualicaps.com/

We partnered with MarketsandMarkets for an assessment study on hard empty capsules. The team was extremely professional in understanding our business requirements and we received timely responses to all our queries. The market intelligence and the recommendations has met our business requirements. We were extremely impressed to see the final study results; it really exceeded our expectations. The market intelligence offered by MarketsandMarkets, and clarity on next steps will help us achieve our business objective for the Year 2021. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.

Bob Williams,

Senior Director Business Development & Innovation

Bracco Diagnostics Inc.,

Italian Multinational in life sciences sector and a World Leader in imaging diagnostics

imaging.bracco.com/us-en

We were pleased with targeted insights that MarketsandMarkets identified from a custom study on the 'Radiation Dose Management Solutions Market'. Your team identified and characterized the market participants as well as underlying trends accurately. This study was useful to Bracco in formulating business strategies for our dose monitoring product lines and we thank MarketsandMarkets for the job well done.

Cody Coonradt,

Market Development and Strategy Manager

3M Health Information Systems,

Leader in Health care Coding, Payment & Analytics Solutions.

www.3m.com/3M/en_US/health-information-systems-us

The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with. As important as the first two are, the third can't be underestimated. MarketsandMarkets, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer.

Their customer first approach and high value engagement model, have given us great analysis and excellent value for money

Previous Next

推荐订阅源

Market Research Reports

High-Throughput Screening (HTS) Market by Instruments (Liquid Handling, Detection, Imaging), Consumables (Reagents, Kits), Software, Services, Technology (Cell-based, High-content, Label-free), Workflow, Application, Competition - Global Forecast to 2031

HIGH THROUGHPUT SCREENING MARKET SIZE, SHARE & GROWTH SNAPSHOT

KEY TAKEAWAYS

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

MARKET DYNAMICS

HIGH THROUGHPUT SCREENING MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

MARKET ECOSYSTEM

MARKET SEGMENTS

REGION

Asia Pacific to be fastest-growing region in global high-throughput screening (HTS) market during forecast period

HIGH THROUGHPUT SCREENING MARKET: COMPANY EVALUATION MATRIX

KEY MARKET PLAYERS

MARKET SCOPE

WHAT IS IN IT FOR YOU: HIGH THROUGHPUT SCREENING MARKET REPORT CONTENT GUIDE

DELIVERED CUSTOMIZATIONS

RECENT DEVELOPMENTS

Table of Contents

Methodology

Secondary Research

Primary Research

Market Size Estimation

High-Throughput Screening (HTS) Market : Top-Down and Bottom-Up Approach

Data Triangulation

Market Definition

Key Stakeholders

Report Objectives

Customization Options

Portfolio Assessment

Company Information

Geographical Analysis

JAYANT RAJPUROHIT

SFI Health,

BEATRIZ DE LA CALLE

Qualicaps,

Bob Williams,

Bracco Diagnostics Inc.,

Cody Coonradt,

3M Health Information Systems,